Obstetrics, gynecology, andrology, sexual and reproductive health

Female genital neoplasms

Guidelines, reviews, epidemiology

 

Cervical cancer

• Africa
  • BMC Women's Health
    • Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective [2016]
  • WHO Regional Office for Africa
    • Framework for the implementation of the global strategy to accelerate the elimination of cervical cancer as a public health problem in the WHO African Region: report of the Secretariat [2021]
    • Strategic planning for cervical cancer prevention and control in Africa: training manual – facilitator manual [2017]
    • Strategic Planning for Cervical Cancer Prevention and Control in Africa: Training Manual - Participants Manual [2017]
    • Information, education and communication for cervical cancer prevention and control in African countries: Training Guide [2017]
    • Assessing Country Capacity and Preparedness for Introducing or Scaling up a Comprehensive Cervical Cancer Prevention and Control Programme: Baseline Report, , December 2014 [2017]
    • Advocacy for cervical cancer prevention and control in Africa: facilitator manual [2017]
    • Cervical cancer
• Americas
  • Pan American Health Organization
    • Plan of Action for Cervical Cancer Prevention and Control 2018-2030 [2018]
• Australia
  • UNSW - The Kirby Institute for infection and immunity in society
    • Cervical Cancer Elimination Report 2021 [2021]
• Botswana
  • Cancer Prevention Research
    • Assessing Nurses’ Adherence to the See-and-Treat Guidelines of Botswana’s National Cervical Cancer Prevention Programme [2020]
  • Frontiers in Oncology
    • Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs [2015]
• Brazil
  • Epidemiologia e Serviços de Saúde
    • Assessment of the production of cervical cancer care procedures in the Brazilian National Health System in 2015 [2018]
  • Revista Brasileira de Ginecologia e Obstetrícia
    • HPV infection - Screening, diagnosis and management of HPV-induced lesions [2021]
• Canada
  • BC Cancer Agency
    • Uterine Cervix
  • Canadian Cancer Society
    • Cervical cancer
  • Public Health Agency of Canada
    • Cervical Cancer
• China
  • Chinese Journal of Cancer Research
    • Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version) [2019]
• Developing countries
  • Indian Journal of Medical and Paediatric Oncology
    • Consensus meeting and update on existing guidelines for management of cervical cancer with special emphasis on the practice in developing countries, including India [2012]
• East Africa
  • Cancers
    • National Policies to Prevent and Manage Cervical Cancer in East African Countries: A Policy Mapping Analysis [2020]
• Europe
  • European Society for Medical Oncology
    • Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2017]
  • European Society of Gynaecological Oncology
    • European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic [2020]
    • The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer [2018]
  • WHO Regional Office for Europe
    • Roadmap to accelerate the elimination of cervical cancer as a public health problem in the WHO European Region 2022–2030: draft for the Seventy-second Regional Committee for Europe Background document [2022]
    • Supporting the prevention, detection and treatment of cervical cancer
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities [2022]
    • Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy [2022]
    • Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up [2019]
    • Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia [2019]
    • Establishment of the Certification System “Gynaecological Dysplasia” in Germany [2014]
• India
  • Indian Journal of Gynecologic Oncology
    • Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and Management [2022]
  • JCO Global Oncology
    • Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India [2021]
  • Journal of Global Oncology
    • National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer [2018]
• International
  • Centers for Disease Control and Prevention
    • CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide [2017]
  • eMedicine
    • Cervical Cancer Guidelines [2018]
  • ESMO Open
    • Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports [2020]
  • Frontiers in Public Health
    • Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation [2021]
  • Gynecologic Cancer Intergroup
    • The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries [2021]
    • Advancing clinical research globally: Cervical cancer research network from Mexico [2018]
    • Advances and Concepts in Cervical Cancer Trials: A Roadmap for the Future [2017]
  • International Collaboration on Cancer Reporting
    • Carcinomas of the Cervix [2021]
  • International Federation of Gynecology and Obstetrics
    • Worldwide initiatives to eliminate cervical cancer [2021]
    • Cancer of the cervix uteri: 2021 update [2021]
    • International Federation of Gynecology and Obstetrics Global Declaration on Cervical Cancer Elimination [2019]
    • Cancer of the cervix uteri [2018]
• Latin America
  • Cancer
    • Cervical cancer control in Latin America: A call to action [2015]
  • Journal of Surgical Oncology
    • Cervical cancer prevention and treatment in Latin America [2017]
• Low and middle income countries
  • Frontiers in Public Health
    • A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities [2021]
  • Gynecologic Cancer Intergroup
    • The Cervix Cancer Research Network: Increasing Access to Cancer Clinical Trials in Low- and Middle-Income Countries [2015]
  • Journal of Medical Internet Research
    • Digital Health Strategies for Cervical Cancer Control in Low- and Middle-Income Countries: Systematic Review of Current Implementations and Gaps in Research [2021]
• PAHO
  • Pan American Health Organization
    • Cervical Cancer
    • A Global Strategy for elimination of cervical cancer
• Poland
  • Ginekologia Polska
    • Possible deferral of diagnostic and therapeutic procedures for patients with abnormal screening tests results in cervical cancer secondary prevention in current SARS-CoV-2 pandemic Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology [2020]
    • Polish recommendations regarding diagnostics and treatment of cervical squamous intraepithelial lesions according to the CAP/ASCCP guidelines [2016]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement [2017]
• Saudi Arabia
  • Annals of Saudi Medicine
    • Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia [2016]
• South Africa
  • National Department of Health
    • Cervical Cancer Prevention and Control Policy [2017]
• South-East Asia
  • WHO Regional Office for South-East Asia
    • Accelerating the elimination of cervical cancer as a public health problem: Towards achieving 90–70–90 targets by 2030 [2022]
    • Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030 [2021]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM guidelines for cervical cancer [2015]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Guidance for cervical screening and management in Sri Lankan health care system [2021]
• Sub-Saharan Africa
  • Frontiers in Global Women's Health
    • Community-Engaged Approaches to Cervical Cancer Prevention and Control in Sub-Saharan Africa: A Scoping Review [2021]
  • Frontiers in Oncology
    • Challenges in Prevention and Care Delivery for Women with Cervical Cancer in Sub-Saharan Africa [2016]
  • Implementation Science
    • Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review [2018]
  • JCO Global Oncology
    • Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management [2021]
• Sweden
  • PLoS ONE
    • Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination [2015]
• Ukraine
  • World Bank
    • Cervical Cancer in Ukraine : The Continuum of Care and Implications for Action [2019]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Cervical cancer
• United States
  • Cancer Epidemiology Biomarkers & Prevention
    • Prevention of Invasive Cervical Cancer in the United States: Past, Present, and Future [2012]
  • Centers for Disease Control and Prevention
    • Human Papillomavirus (HPV) Infection - STI Treatment Guidelines [2021]
    • HPV
    • Cervical Cancer
  • M.D. Anderson Cancer Center
    • Cervical Cancer
  • National Cancer Institute
    • Cervical Cancer Prevention (PDQ®)
  • National Comprehensive Cancer Network
    • Cervical Cancer
  • OncoLink
    • Cervical Cancer
  • Society of Gynecologic Oncology
    • Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations [2020]
• Western Pacific
  • WHO Western Pacific Region
    • Strategic framework for the comprehensive prevention and control of cervical cancer in the Western Pacific Region 2023-2030 [2023]
• WHO
  • International Agency for Research on Cancer
    • Cervical cancer
  • World Health Organization
    • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [2021]
    • Implementation of post-market surveillance in cervical cancer programmes [2021]
    • WHO technical guidance and specifications of medical devices for screening and treatment of precancerous lesions in the prevention of cervical cancer [2020]
    • Global strategy to accelerate the elimination of cervical cancer as a public health problem [2020]
    • Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes [2019]
    • A handbook on how to implement mCervicalCancer [2017]
    • Comprehensive cervical cancer control: a guide to essential practice - Second edition [2014]
    • Comprehensive cervical cancer prevention and control - a healthier future for girls and women. WHO guidance note [2013]
    • Strengthening cervical cancer prevention and control: report of the GAVI-UNFPA-WHO meeting [2010]
    • Cervical cancer: Fact sheet
    • Cervical cancer
    • Cervical Cancer Elimination Initiative
• Zimbabwe
  • Pan African Medical Journal
    • The COVID-19 pandemic and its implications for cervical cancer treatment and prevention in Zimbabwe: perspectives and recommendations [2021]
    • Cervical cancer in Zimbabwe: a situation analysis [2017]
• {Related topics}
  • Guidelines
    • HIV/AIDS and human papillomavirus
    • Gynecologic oncology
    • Cervical cancer: vaccine
    • Cervical cancer: treatment
    • Cervical cancer: screening, prevention
    • Cervical cancer: imaging
    • Cervical cancer: epidemiology
    • Cervical cancer: colposcopy, cytopathology, histopathology
    • Cervical cancer: HPV testing

Cervical cancer: colposcopy, cytopathology, histopathology

• Africa
  • PLoS ONE
    • Factors Affecting Compliance with Clinical Practice Guidelines for Pap Smear Screening among Healthcare Providers in Africa: Systematic Review and Meta-Summary of 2045 Individuals [2013]
• Australasia
  • Royal College of Pathologists of Australasia
    • Cervix excisions including LLETZ and cone biopsies
• Australia
  • Medical Services Advisory Committee
    • Cell enrichment liquid based cytology in routine screening for the prevention of cervical cancer [2013]
• Canada
  • Ontario Health
    • Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario [2016]
    • The organization of colposcopy services in Ontario: recommended framework [2015]
• China
  • Bulletin of the World Health Organization
    • Cervical cancer screening aided by artificial intelligence, China [2023]
• International
  • Acta Cytologica
    • The Pap Test and Bethesda 2014 [2015]
  • International Society of Gynecological Pathologists
    • Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists [2021]
    • Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists [2021]
    • The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists [2021]
    • The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists [2021]
    • The ISGyP Endocervical Adenocarcinoma Project: Master Plan Summary, Acknowledgment of Participants, and Participant Responses to Final Recommendations of the Expert Panels [2021]
    • Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists [2021]
    • Grading of Endocervical Adenocarcinomas: Review of the Literature and Recommendations From the International Society of Gynecological Pathologists [2021]
    • Endocervical Adenocarcinoma, Gross Examination, and Processing, Including Intraoperative Evaluation: Recommendations From the International Society of Gynecological Pathologists [2021]
  • Journal of Gynecologic Oncology
    • Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri [2019]
  • Medical Science Monitor
    • Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis [2022]
• Italy
  • BMC Health Services Research
    • Rationale and development of an on-line quality assurance programme for colposcopy in a population-based cervical screening setting in Italy [2013]
• Japan
  • PLoS ONE
    • Current status of cervical cytology during pregnancy in Japan [2021]
• Malaysia
  • Malaysian Family Physician
    • Non-Adherence to recommended Pap smear screening guidelines and its associated factors among women attending health clinic in Malaysia [2018]
• Poland
  • Ginekologia Polska
    • COLPOSCOPY 2020 — COLPOSCOPY PROTOCOLS: A Summary of the Clinical Experts Consensus Guidelines of the Polish Society of Colposcopy and Cervical Pathophysiology and the Polish Society of Gynaecologists and Obstetricians [2020]
• Republic of Korea
  • Journal of Pathology and Translational Medicine
    • Continuous quality improvement program and its results of Korean Society for Cytopathology [2020]
    • Current Cytology Practices in Korea: A Nationwide Survey by the Korean Society for Cytopathology [2017]
  • Scientific Reports
    • Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems [2021]
• Republic of Korea, United States
  • Journal of Pathology and Translational Medicine
    • Clinical management of abnormal Pap tests: differences between US and Korean guidelines [2020]
• Sweden
  • BMJ
    • Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study [2016]
• Trinidad and Tobago
  • West Indian Medical Journal
    • Cervical Smears at Public Health Centres in Eastern Trinidad: Coverage and Follow-up, 2009–2010 [2014]
• Turkey
  • Turkish Journal of Pathology
    • What does the Data of 354,725 Patients from Turkey Tell Us About Cervical Smear Epithelial Cell Abnormalities? - The Epithelial Cell Abnormality Rate is Increasing - Quality Control Studies and Corrective Activity are Musts [2017]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I [2018]
  • Public Health England
    • Human papillomavirus (HPV) primary screening: colposcopy management
    • Cervical screening: programme and colposcopy management
    • Cervical screening: histopathology reporting handbook
    • Cervical screening: gynaecological cytopathology EQA scheme
    • Cervical screening: cytology reporting failsafe
  • Royal College of Pathologists
    • Dataset for histopathological reporting of cervical neoplasia [2021]
    • BPR Clinical responsibility for cytology services [2019]
• United States
  • American Journal of Clinical Pathology
    • NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA [2014]
  • American Society for Colposcopy and Cervical Pathology
    • A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance [2020]
    • Colposcopy Standards [2017]
    • Guidelines - ASCCP
  • CA: A Cancer Journal for Clinicians
    • The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer [2021]
  • Centers for Disease Control and Prevention
    • Pap Tests
  • Obstetrics & Gynecology
    • Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines [2019]
    • Revised Terminology for Cervical Histopathology and Its Implications for Management of High-Grade Squamous Intraepithelial Lesions of the Cervix [2012]
    • Adherence to Conservative Management Recommendations for Abnormal Pap Tests in Adolescents [2012]
  • Preventive Medicine
    • Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines [2014]
• WHO
  • International Agency for Research on Cancer
    • Colposcopy and Treatment of Cervical Precancer [2017]
    • Atlas of Colposcopy: Principles and Practice [2017]
    • WHO histological classification of tumours of the uterine cervix [2004]
    • The Bethesda System [2004]
    • TNM / FIGO [2004]
    • Histopathology of the uterine cervix - digital atlas [2004]
    • Cytopathology of the uterine cervix - digital atlas [2004]
    • Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginner's Manual [2003]
• {Related topics}
  • Guidelines
    • Cervical cancer: screening, prevention
    • Cervical cancer

Cervical cancer: epidemiology

• Africa
  • WHO Regional Office for Africa
    • Cancer of the cervix in the African Region: current situation and way forward [2011]
• Australia
  • Cancer Australia
    • Report to the nation - cervical cancer 2012 [2012]
  • PLoS ONE
    • Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012) [2018]
• Brazil
  • Annals of Global Health
    • The Global Burden of Disease Study Estimates of Brazil’s Cervical Cancer Burden [2020]
  • Journal of Ambulatory Care Management
    • Primary Health Care and Cervical Cancer Mortality Rates in Brazil [2017]
• Brunei Darussalam
  • Singapore Medical Journal
    • Cervical cancer in Brunei Darussalam [2012]
• Bulgaria
  • Germs
    • An overview of cervical cancer epidemiology and prevention in Bulgaria [2020]
• Canada
  • Canadian Cancer Society
    • Cervical cancer statistics
• China
  • BMC Public Health
    • Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis [2021]
• China, United States
  • International Journal of Environmental Research and Public Health
    • Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis [2016]
• Colombia
  • Colombia Médica
    • Epidemiology of cervical cancer in Colombia [2012]
• East-Central Europe
  • International Journal of Environmental Research and Public Health
    • Cervical Cancer Mortality in East-Central European Countries [2020]
• Eastern and Southern Africa
  • Women's Health
    • Human Papilloma Virus infection and cervical cancer among women who sell sex in Eastern and Southern Africa: A scoping review [2021]
• Ethiopia
  • Ethiopian Journal of Health Sciences
    • Prevalence and Associated Factors of Precancerous Cervical Lesions among Women in Ethiopia: A Systematic Review and Meta-Analysis [2021]
  • PLoS ONE
    • Precancerous lesions of the cervix and its determinants among Ethiopian women: Systematic review and meta-analysis [2020]
• Finland
  • Cancer Control
    • On Exploring Hidden Structures Behind Cervical Cancer Incidence [2018]
• Germany
  • BMC Cancer
    • Cancer incidence in Germany attributable to human papillomavirus in 2013 [2017]
• Grenada
  • Revista Panamericana de Salud Pública
    • Prevalence of cervical cancer and associated mortality in Grenada, 2000–2010 [2016]
• India
  • BMC Cancer
    • Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study [2022]
  • International Journal of Women's Health
    • Epidemiology of cervical cancer with special focus on India [2015]
• International
  • American Journal of Epidemiology
    • Predicting Cohort-Specific Cervical Cancer Incidence From Population-Based Surveys of Human Papilloma Virus Prevalence: A Worldwide Study [2022]
  • BMC Public Health
    • Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019 [2021]
  • International Journal of Cancer
    • Worldwide burden of cancer attributable to HPV by site, country and HPV type [2017]
  • Lancet Global Health
    • Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [2020]
  • PLoS ONE
    • Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis [2022]
  • Preventive Medicine
    • The role and utility of population-based cancer registries in cervical cancer surveillance and control [2021]
• Israel
  • Israel Medical Association Journal
    • Cervical Neoplasia in Israeli Jewish Women: A Review of the Characteristics in a Low Risk Population [2011]
• Japan
  • BMC Health Services Research
    • Cost of illness of the Cervical Cancer of the uterus in Japan - a time trend and future projections [2015]
  • Cancer Science
    • Trends in cervical cancer incidence and mortality of young and middle adults in Japan [2022]
• Kazakhstan
  • Asian Pacific Journal of Cancer Prevention
    • New Trends of Cervical Cancer Incidence in Kazakhstan [2021]
• Latin America and the Caribbean
  • BMC Public Health
    • Cervical cancer mortality among young women in Latin America and the Caribbean: trend analysis from 1997 to 2030 [2022]
• Low and middle income countries
  • Lancet
    • Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries [2020]
• Netherlands
  • Cancer Medicine
    • Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013 [2017]
• Nordic countries
  • Acta Obstetricia et Gynecologica Scandinavica
    • An overview of cervical cancer epidemiology and prevention in Scandinavia [2018]
• Norway
  • BMC Cancer
    • Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study [2021]
  • BMC Women's Health
    • Cervical cancer in women under 30 years of age in Norway: a population-based cohort study [2021]
• Peru
  • BMC Public Health
    • Cervical cancer mortality in Peru: regional trend analysis from 2008–2017 [2021]
• Republic of Korea
  • International Journal of Environmental Research and Public Health
    • The Burden of Cervical Cancer in Korea: A Population-Based Study [2020]
  • Journal of Gynecologic Oncology
    • Epidemiologic characteristics of cervical cancer in Korean women [2014]
  • PLoS ONE
    • Trends in the Incidence of In Situ and Invasive Cervical Cancer by Age Group and Histological Type in Korea from 1993 to 2009 [2013]
• Romania
  • Medicina
    • Cervical Cancer Mortality in Romania: Trends, Regional and Rural–Urban Inequalities, and Policy Implications [2021]
• Saudi Arabia
  • Frontiers in Oncology
    • HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination [2014]
• Singapore
  • Ministry of Health Singapore
    • Cervical Cancer Epidemiology and Screening Behaviour in Singapore [2018]
• South Africa
  • International Journal of Cancer
    • Temporal trends in the epidemiology of cervical cancer in South Africa (1994–2012) [2018]
• Spain
  • BMC Cancer
    • The end of the decline in cervical cancer mortality in Spain: trends across the period 1981–2012 [2015]
• Sub-Saharan Africa
  • BMC Cancer
    • Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review [2019]
  • British Journal of Cancer
    • Trends in cervical cancer incidence in sub-Saharan Africa [2020]
  • Tropical Medicine & International Health
    • Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review [2009]
  • Vaccine
    • The Burden of Human Papillomavirus Infections and Related Diseases in Sub-Saharan Africa [2013]
• Sweden
  • Gynecologic Oncology
    • Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study [2021]
• United Kingdom
  • Cancer Research UK
    • Cervical cancer statistics
• United States
  • Cancer
    • Increased Age and Race-Specific Incidence of Cervical Cancer After Correction for Hysterectomy Prevalence in the United States From 2000 to 2009 [2014]
  • Cancer Control
    • Cervical Cancer Among Older Women: Analyses of Surveillance, Epidemiology and End Results Program Data [2020]
  • Centers for Disease Control and Prevention
    • Human Papillomavirus–Attributable Cancers — United States, 2012–2016 [2019]
    • Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016 [2019]
    • Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015 [2018]
    • Human Papillomavirus–Associated Cancers — United States, 2008–2012 [2016]
    • Vital Signs: Cervical Cancer Incidence, Mortality, and Screening — United States, 2007–2012 [2014]
    • Human Papillomavirus–Associated Cancers — United States, 2004–2008 [2012]
  • Cureus
    • Prevalence and Sociodemographic Covariates of Cervical Cancer and Its Association With Menstrual Irregularities: Findings From the 2017 National Inpatient Sample Database [2021]
  • Gynecologic Oncology
    • Trends in cervical cancer incidence in younger US women from 2000-2013 [2017]
  • Journal of Gynecologic Oncology
    • Trends in single women with malignancy of the uterine cervix in United States [2018]
  • National Cancer Institute
    • Cervical Cancer
  • PLoS ONE
    • Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States [2017]
• Vietnam, Republic of Korea
  • Epidemiology and Health
    • Incidence and mortality of cervical cancer in Vietnam and Korea (1999-2017) [2020]
• WHO
  • International Agency for Research on Cancer
    • Cervix uteri fact sheet
  • World Health Organization
    • Complete cervical cancer profile sets [2021]
    • Cervix uteri cancer
    • Cervical cancer country profiles
• {Related topics}
  • Guidelines
    • Cervical cancer

Cervical cancer: HPV testing

• Africa
  • PLoS ONE
    • Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis [2015]
• Australia
  • Australian Family Physician
    • HPV testing in the National Cervical Screening Program – when is it recommended? [2013]
  • Australian Journal of General Practice
    • Human papillomavirus testing as part of the renewed National Cervical Screening Program [2018]
• Bahrain
  • BMC Cancer
    • An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain [2014]
• Bhutan
  • BMC Infectious Diseases
    • Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme [2014]
• Brazil
  • Revista Brasileira de Ginecologia e Obstetrícia
    • Cervical Cancer Screening with HPV Testing: Updates on the Recommendation [2022]
    • Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil [2018]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • HPV Testing for Primary Cervical Cancer Screening: Recommendations Report [2019]
  • Canadian Family Physician
    • Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women [2017]
  • Public Health Agency of Canada
    • Human Papillomavirus (HPV)
• China
  • Archives of Gynecology and Obstetrics
    • Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis [2020]
  • BMC Medicine
    • Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study [2021]
• Croatia
  • PLoS ONE
    • Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia [2017]
• Denmark
  • Obstetrics & Gynecology
    • Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years [2021]
  • PLoS ONE
    • Histological outcomes in HPV-screened elderly women in Denmark [2021]
• El Salvador
  • International Journal of Cancer
    • The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador [2015]
  • Journal of Lower Genital Tract Disease
    • Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador [2016]
• Europe
  • Clinical Microbiology and Infection
    • Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans [2020]
  • Life
    • Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening [2020]
• Finland
  • BMC Women's Health
    • The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland [2015]
• Gulf Cooperation Council
  • Cancer Cytopathology
    • Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology [2019]
• International
  • BMJ Global Health
    • HPV self-sampling for cervical cancer screening: a systematic review of values and preferences [2021]
  • Cancer Prevention Research
    • A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus–positive and -Negative Cervical Precancers [2020]
  • Clinical Microbiology and Infection
    • Commercially available molecular tests for human papillomaviruses: a global overview [2020]
    • Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? [2015]
  • Diagnostic Cytopathology
    • Statement on HPV DNA Test Utilization [2009]
  • International Journal of Cancer
    • Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older [2009]
  • PLoS ONE
    • Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide [2014]
• Ireland
  • Health Information and Quality Authority
    • HTA of HPV testing for cervical cancer screening [2017]
• Italy
  • Epidemiologia e Prevenzione
    • hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi) [2015]
    • A first survey of HPV-based screening in routine cervical cancer screening in Italy [2015]
• Japan
  • Asian Pacific Journal of Cancer Prevention
    • Prevalence and Risk Factors of Human Papillomavirus Infection among Japanese Female People: A Nationwide Epidemiological Survey by Self-Sampling [2021]
• Latin America
  • PLoS ONE
    • Type-Specific HPV Prevalence in Cervical Cancer and High-Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta-Analysis [2011]
• Low and middle income countries
  • BMC Cancer
    • Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study [2017]
• Middle East, North Africa
  • Journal of Infection and Public Health
    • Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis [2020]
• Montenegro
  • Acta Clinica Croatica
    • HPV typing as a screening program for prevention and early detection of cervical cancer in different Montenegro regions [2020]
• Netherlands
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study [2021]
  • International Journal of Cancer
    • Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening [2016]
    • Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended? [2014]
  • Preventive Medicine
    • HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme [2019]
• New Zealand
  • PLoS ONE
    • Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand [2016]
• Nigeria
  • Asian Pacific Journal of Cancer Prevention
    • Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-Analysis [2020]
• PAHO
  • Pan American Health Organization
    • Integrating HPV testing in cervical cancer screening program: a manual for program managers [2016]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology [2020]
• Romania
  • Annals of Global Health
    • HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions [2019]
• Singapore
  • Society for Colposcopy and Cervical Pathology of Singapore
    • SCCPS Scientific Committee Position Paper on Primary HPV Screening for Cervical Cancer Prevention [2016]
• Slovenia
  • Acta Dermatovenerologica Alpina, Pannonica et Adriatica
    • A review of 20 years of HPV research in Slovenia [2011]
• Spain
  • BMC Women's Health
    • Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain [2021]
• Sub-Saharan Africa
  • Implementation Science Communications
    • A systematic review of randomized control trials of HPV self-collection studies among women in sub-Saharan Africa using the RE-AIM framework [2021]
  • Infectious Agents and Cancer
    • Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials [2021]
• Sweden
  • PLoS ONE
    • Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden [2020]
• Turkey
  • Turkish Journal of Obstetrics and Gynecology
    • Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey [2021]
• United Kingdom
  • Public Health England
    • Human papillomavirus (HPV): primary screening protocol
    • Cervical screening: primary HPV screening implementation
    • Cervical screening: pathway for acceptance of new HPV tests
    • Cervical screening: laboratory testing for human papillomavirus
    • Cervical screening: laboratory HPV testing and cytology services
    • Cervical screening: acceptable HPV tests
  • Public Health Scotland
    • Women's understanding of the introduction of HPV testing to the cervical screening programme in Scotland [2019]
• United States
  • Acta Cytologica
    • 2013 Statement on Human Papillomavirus DNA Test Utilization [2014]
  • Agency for Healthcare Research and Quality
    • Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force [2018]
  • American Journal of Managed Care
    • The Budget Impact of Cervical Cancer Screening Using HPV Primary Screening [2016]
  • American Society for Colposcopy and Cervical Pathology
    • A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines [2020]
  • Cancer Cytopathology
    • Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today [2014]
  • Journal of Women's Health
    • The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis [2016]
    • Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening [2013]
  • Preventive Medicine
    • Primary HPV testing recommendations of US providers, 2015 [2017]
  • Society of Gynecologic Oncology
    • Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance [2015]
    • Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test  [2015]
• WHO
  • International Agency for Research on Cancer
    • Using HPV tests for cervical cancer screening and managing HPV-positive women – a practical online guide [2023]
  • World Health Organization
    • WHO recommendations on self-care interventions: human papillomavirus (HPV) self-sampling as part of cervical cancer screening and treatment, 2022 update [2023]
    • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV): web annex [2021]
    • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV) [2021]
    • Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer [2020]
    • Human papillomavirus (HPV) self-sampling as part of cervical cancer screening [2020]
    • Human papillomavirus laboratory manual [2010]
• {Related topics}
  • Guidelines
    • Cervical cancer: screening, prevention
    • Cervical cancer

Cervical cancer: imaging

• Brazil
  • Revista da Associação Médica Brasileira
    • Cervical cancer - staging and restaging with 18F-FDG PET/CT [2019]
• United Kingdom
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • Evaluating PET–CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis [2014]
• United States
  • American College of Radiology
    • Pretreatment Planning of Invasive Cancer of the Cervix
• {Related topics}
  • Guidelines
    • Cervical cancer

Cervical cancer: screening, prevention

• Africa
  • Global Health Action
    • Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review [2019]
• Australia
  • Australian Institute of Health and Welfare
    • National Cervical Screening Program Data Dictionary: Version 1.1 [2022]
    • National Cervical Screening Program monitoring report 2021 [2021]
    • Cervical screening in Australia 2019 [2019]
    • Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia [2019]
  • Australian Journal of General Practice
    • A new era in cervical cancer prevention [2018]
  • Lancet Public Health
    • Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program [2017]
  • Medical Services Advisory Committee
    • Improvements to the National Cervical Screening Program Self-Collection Policy [2021]
    • National Cervical Screening Program renewal [2014]
  • Public Health Research and Practice
    • Lessons from the renewal of the National Cervical Screening Program in Australia [2019]
• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Cervical cancer screening in Australia and New Zealand [2020]
• Belgium, Switzerland
  • BMC Public Health
    • Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities [2020]
• Bolivia
  • Rural and Remote Health
    • Findings and lessons learned from a multi-partner collaboration to increase cervical cancer prevention efforts in Bolivia [2013]
• Brazil
  • BMC Cancer
    • Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013 [2018]
• Brazil, Chile
  • Ciência & Saúde Coletiva
    • Cervical cancer guidelines, prevention and screening strategies: experiences from Brazil and Chile [2021]
• Cameroon
  • BMC Public Health
    • Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys [2021]
• Canada
  • Canadian Family Physician
    • The pandemic and cervical cancer screening: Is it finally time to adopt HPV self-swabbing tests in Canada? [2022]
    • Cervical cancer screening for young women [2020]
    • Missed connections: Unintended consequences of updated cervical cancer screening guidelines on screening rates for sexually transmitted infections [2015]
  • Canadian Task Force on Preventive Health Care
    • Cervical Cancer (2013) [2013]
  • CMAJ
    • Evidence that supports policies to delay cervical screening until after age 25 years [2017]
  • Journal of Obstetrics and Gynaecology Canada
    • Cervical Cancer Screening in Canada [2019]
• Central Asia, Eastern Europe
  • United Nations Population Fund
    • Preventing Cervical Cancer in Eastern Europe & Central Asia [2021]
• China
  • BMC Medicine
    • Development of models for cervical cancer screening: construction in a cross-sectional population and validation in two screening cohorts in China [2021]
  • China CDC Weekly
    • Cervical Cancer Screening Rates Among Chinese Women — China, 2015 [2020]
  • Chinese Journal of Cancer Research
    • Cervical cancer: Epidemiology, risk factors and screening [2020]
  • Japanese Journal of Clinical Oncology
    • Implementation of cervical cancer screening and prevention in China—challenges and reality [2015]
  • Oncologist
    • Cervical Cancer Screening Among Adult Women in China, 2010 [2015]
• Côte d'Ivoire
  • BMC Public Health
    • Cervical cancer screening by visual inspection in Cote d'Ivoire, operational and clinical aspects according to HIV status [2012]
• Developing countries
  • BMC Women's Health
    • Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review [2010]
  • World Health Organization
    • Cervical cancer screening in developing countries [2002]
• East Africa
  • JCO Global Oncology
    • Burden of Risk Factors for Cervical Cancer Among Women Living in East Africa: An Analysis of the Latest Demographic Health Surveys Conducted Between 2014 and 2017 [2021]
• Ethiopia
  • PLoS ONE
    • Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis [2021]
• Europe
  • European Society of Gynaecological Oncology
    • Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) [2020]
  • International Journal of Cancer
    • The European response to the WHO call to eliminate cervical cancer as a public health problem [2021]
  • PLoS ONE
    • The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort [2016]
  • WHO Regional Office for Europe
    • Cervical cancer testing in the WHO European Region [2021]
• Finland
  • International Journal of Environmental Research and Public Health
    • Cervical Cancer Screening Participation among Women of Russian, Somali, and Kurdish Origin Compared with the General Finnish Population: A Register-Based Study [2020]
• France
  • PLoS ONE
    • Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France [2020]
• Germany
  • European Journal of Obstetrics & Gynecology and Reproductive Biology
    • A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany [2017]
  • Materia Socio-Medica
    • Implementation of the Program for Early Detection of Cervical Cancer in the Federal Republic of Germany [2020]
• Ghana
  • Ghana Medical Journal
    • Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination [2018]
• Hong Kong
  • Centre for Health Protection
    • Recommendations on Prevention and Screening for Cervical Cancer For Health Professionals [2021]
  • Hong Kong College of Obstetricians and Gynaecologists
    • Guidelines for Cervical Cancer Prevention and Screening [2016]
• India
  • Cancer Epidemiology
    • Implementing Community-based Cervical Cancer Screening Programs using Visual Inspection with Acetic Acid in India: A Systematic Review [2017]
  • Centers for Disease Control and Prevention
    • Establishing Baseline Cervical Cancer Screening Coverage — India, 2015–2016 [2019]
  • Indian Journal of Medical Research
    • Screening for cervical cancer: Choices & dilemmas [2021]
  • PLoS ONE
    • Cost effectiveness of strategies for cervical cancer prevention in India [2020]
  • Women's Health
    • Knowledge, attitude, and practice on screening toward cervical cancer among health professionals in India—A review [2021]
• Indonesia
  • Global Health Action
    • Facilitators and barriers for the delivery and uptake of cervical cancer screening in Indonesia: a scoping review [2021]
• International
  • BMC Women's Health
    • Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review [2021]
  • Geneva Foundation for Medical Education and Research
    • Comprehensive Visual Inspection of the Cervix with Acetic Acid (VIA) and Lugol’s Iodine (VILI) [2014]
  • Globalization and Health
    • Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study [2022]
  • International Papillomavirus Society
    • IPVS policy statement. Equity in cervical cancer prevention: for all and not just for some [2020]
  • International Planned Parenthood Federation
    • IMAP statement on preventing cervical cancer [2016]
  • Journal of Oncology
    • Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature [2020]
  • Papillomavirus Research
    • HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control [2019]
  • Scientific Reports
    • Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis [2022]
• Iran
  • BMC Public Health
    • Disparities in cervical cancer screening participation in Iran: a cross-sectional analysis of the 2016 nationwide STEPS survey [2020]
  • International Journal of Health Policy and Management
    • Priority Setting for Improvement of Cervical Cancer Prevention in Iran [2015]
  • PLoS ONE
    • Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer [2016]
• Ireland
  • Department of Health
    • Scoping Inquiry into the CervicalCheck Screening Programme [2019]
    • CervicalCheck [2019]
• Italy
  • Epidemiologia e Prevenzione
    • The diffusion of screening programmes in Italy, years 2011-2012 [2015]
    • Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity [2015]
• Japan
  • International Journal of Gynecological Cancer
    • Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan [2017]
  • Japanese Journal of Clinical Oncology
    • The Japanese Guideline for Cervical Cancer Screening [2010]
• Latvia
  • Acta Dermatovenerologica Alpina, Pannonica et Adriatica
    • Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011) [2013]
• Low and middle income countries
  • JAMA
    • Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries [2020]
  • Lancet
    • Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries [2020]
• Low-resource settings
  • Cancer Medicine
    • Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings [2017]
  • International Journal of Cancer
    • To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings [2017]
• Malawi
  • BMC Public Health
    • Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study [2016]
  • Global Health Action
    • Health systems challenges in cervical cancer prevention program in Malawi [2015]
• Mexico
  • Salud Pública de México
    • Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute [2014]
    • Cost analysis of different cervical cancer screening strategies in Mexico [2014]
• Netherlands
  • BMJ
    • Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study [2017]
  • PLoS ONE
    • Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis [2016]
• Netherlands, United States
  • Milbank Quarterly
    • Cervical Cancer Screening in the United States and the Netherlands: A Tale of Two Countries [2012]
• New Zealand
  • Ministry of Health New Zealand
    • Parliamentary Review Committee Report April 2019 [2019]
    • National Cervical Screening Programme: changing the primary laboratory test [2015]
  • National Screening Unit
    • National Cervical Screening Programme
• Nigeria
  • Cancer Reports
    • Factors influencing cervical cancer screening practice among female health workers in Nigeria: A systematic review [2021]
  • Nigerian Journal of Clinical Practice
    • Towards improving cervical cancer screening in Nigeria: A review of the basics of cervical neoplasm and cytology [2012]
• Nigeria, Nordic countries
  • International Health
    • A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence [2021]
• Nordic countries
  • British Journal of Cancer
    • 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence [2014]
• Norway
  • International Journal of Cancer
    • The value of improving failures within a cervical cancer screening program: An example from Norway [2014]
• Poland
  • Annals of Agricultural and Environmental Medicine
    • New directions in cervical cancer prophylaxis worldwide and in Poland – Case study of the Polish rural female population [2017]
    • Effectiveness of the National Population-Based Cervical Cancer Screening Programme in Poland--outcomes, problems and possible solutions 7 years after implementation [2013]
  • BMC Cancer
    • The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines [2015]
  • Ginekologia Polska
    • Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology — a summary January 2021 [2021]
  • PLoS ONE
    • Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland [2016]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020 [2022]
    • Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013 [2021]
    • Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009–2014 [2017]
    • The Korean guideline for cervical cancer screening [2015]
    • Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition [2013]
  • Obstetrics & Gynecology Science
    • Proposal for cervical cancer screening in the era of HPV vaccination [2018]
• Romania
  • International Journal of Environmental Research and Public Health
    • Challenges in the Prevention of Cervical Cancer in Romania [2021]
• Singapore
  • Singapore Medical Journal
    • Cervical cancer screening and vaccination: understanding the latest guidelines [2022]
    • Evaluation of the National Cervical Cancer Screening Programme in Singapore [2013]
  • Society for Colposcopy and Cervical Pathology of Singapore
    • Management Guidelines for Cervical Screening & Preinvasive Disease of the Cervix [2019]
• Sub-Saharan Africa
  • BMC Public Health
    • Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model [2020]
  • BMJ
    • Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies [2015]
• Sweden
  • PLoS Medicine
    • Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden [2017]
  • PLoS ONE
    • Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study [2018]
• Switzerland
  • European Journal of Public Health
    • Cervical cancer screening in Switzerland: cross-sectional trends (1992-2012) in social inequalities [2016]
  • Swiss Medical Weekly
    • Cervical cancer screening in Switzerland: time to rethink the guidelines [2015]
• Taiwan
  • International Journal for Equity in Health
    • Changes in the magnitude of social inequality in the uptake of cervical cancer screening in Taiwan, a country implementing a population-based organized screening program [2014]
• Thailand
  • Asian Pacific Journal of Cancer Prevention
    • National Cervical Cancer Screening in Thailand [2021]
• United Kingdom
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales [2021]
  • British Journal of Cancer
    • Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses [2021]
  • British Journal of General Practice
    • Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study [2014]
  • Faculty of Sexual & Reproductive Healthcare
    • FSRH, RCOG, BSCCP & Jo’s Cervical Cancer Trust Joint Position Statement Cervical Screening [2019]
  • Healthcare Improvement Scotland
    • Cervical screening standards
  • HSC Public Health Agency
    • Northern Ireland cervical screening programme: information for primary care and smear takers [2017]
  • Journal of Medical Screening
    • Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study [2021]
    • Cervical screening attendance and cervical cancer risk among women who have sex with women [2021]
  • NHS Digital
    • Cervical Screening (Quarterly)
  • Preventive Medicine
    • Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study [2021]
  • Public Health England
    • NHS cervical screening (CSP) programme
    • Health matters: making cervical screening more accessible
    • Cervical screening: programme overview
    • Cervical screening: professional guidance
    • Cervical screening: data and research
    • Cervical screening programme: standards
  • Public Health Scotland
    • Cervical screening toolkit [2016]
    • Scottish cervical screening programme statistics
    • Scottish Cervical Screening Programme primary care resources
  • Royal College of Obstetricians and Gynaecologists
    • Progress in Cervical Screening in the UK [2016]
• United States
  • Agency for Healthcare Research and Quality
    • Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [2011]
    • Screening for Cervical Cancer [2011]
  • American Cancer Society
    • Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society [2020]
    • Cervical Cancer Screening Guidelines
  • American College of Obstetricians and Gynecologists
    • Updated Cervical Cancer Screening Guidelines [2021]
    • Cervical Cancer Screening in Low-Resource Settings [2015]
  • American College of Physicians
    • Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians [2015]
  • American Family Physician
    • Cervical Cancer Screening [2018]
  • American Society for Colposcopy and Cervical Pathology
    • Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines [2020]
    • Reporting and Assessing the Quality of Diagnostic Accuracy Studies for Cervical Cancer Screening and Management [2020]
    • Moving forward—the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories [2020]
    • Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests [2020]
    • An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines [2020]
    • 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation [2020]
    • 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors [2020]
  • American Society of Clinical Oncology
    • Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline [2017]
    • Secondary Prevention of Cervical Cancer Resource-Stratified Guideline
  • Annals of Internal Medicine
    • Inefficiencies and high-value improvements in U.S. cervical cancer screening practice: A cost-effectiveness analysis [2015]
  • ASCO Educational Book
    • State of the Science: Screening, Surveillance, and Epidemiology of HPV-Related Malignancies [2021]
  • Cancer
    • Cervical Cancer Screening and Follow-Up in 4 Geographically Diverse US Health Care Systems, 1998 Through 2007 [2015]
  • Cancer Causes and Control
    • Use of cervical cancer preventive services among US women aged 21–29: an assessment of the 2010 Affordable Care Act rollout through 2018 [2020]
    • Estimating the Impact of Increasing Cervical Cancer Screening in the National Breast and Cervical Cancer Early Detection Program among Low-Income Women in the U.S [2020]
  • Cancer Cytopathology
    • Comparison of Cervical Cancer Screening Results Among 256,648 Women in Multiple Clinical Practices [2015]
  • Centers for Disease Control and Prevention
    • Trends in Cervical Cancer Screening in Title X-Funded Health Centers — United States, 2005–2015 [2017]
    • Cervical Cancer Screening Among Women by Hysterectomy Status and Among Women Aged >=65 Years — United States, 2000–2010 [2013]
    • Cervical Cancer Screening Among Women Aged 18–30 Years — United States, 2000–2010 [2013]
    • Cervical Cancer is Preventable
  • Cleveland Clinic Journal of Medicine
    • Risk-based guidelines: Redefining management of abnormal cervical cancer screening results [2021]
  • Health Services Research and Managerial Epidemiology
    • Ending Cervical Cancer Screening in Low-Risk Women After Age 65: Understanding Barriers to Adherence With Evidence-Based Guidelines Among Primary Care Providers [2018]
  • JAMA Network Open
    • Assessment of US Preventive Services Task Force Guideline–Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019 [2022]
    • Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014 [2021]
  • Journal of Cancer Education
    • Increasing Cervical Cancer Screening Among US Hispanics/Latinas: A Qualitative Systematic Review [2015]
  • Journal of Clinical Medicine
    • Current Cervical Carcinoma Screening Guidelines [2015]
  • Journal of Lower Genital Tract Disease
    • The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity? [2018]
    • Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines [2017]
    • Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines [2013]
  • Journal of the National Cancer Institute
    • Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus [2017]
  • National Cancer Institute
    • Cervical Cancer Screening (PDQ®)
  • Oncology Nursing Forum
    • Cervical Cancer Screening Among Arab Women in the United States: An Integrative Review [2017]
  • Preventive Medicine
    • Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities [2021]
    • Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests? [2020]
    • Changes to cervical cancer prevention guidelines: Effects on screening among U.S. women ages 15–29 [2012]
  • Society for Women's Health Research
    • Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers [2021]
  • U.S. Preventive Services Task Force
    • Cervical Cancer: Screening [2018]
• WHO
  • International Agency for Research on Cancer
    • Cervical Cancer Screening [2022]
    • Atlas of visual inspection of the cervix with acetic acid for screening, triage, and assessment for treatment [2020]
    • A practical manual on visual screening for cervical neoplasia [2003]
  • World Health Organization
    • Monitoring national cervical cancer prevention and control programmes [2013]
    • Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy [2012]
    • Screening for cervical cancer
    • Coverage of national cervical cancer screening program
    • Cervical cancer screening - Response by country
    • Cervical cancer screening (Global Health Observatory)
• {Related topics}
  • Guidelines
    • Cervical cancer: vaccine
    • Cervical cancer: colposcopy, cytopathology, histopathology
    • Cervical cancer: HPV testing
    • Cervical cancer

Cervical cancer: treatment

• Australia
  • Cancer Australia
    • Management of women with stage IB2 cervical cancer with treatments other than chemoradiotherapy: A systematic review [2015]
    • Management of women with stage IB2 cervical cancer with treatments other than chemoradiotherapy: A summary of the evidence [2015]
  • Journal of Oncology
    • Excisional Treatment of Cervical Dysplasia in Australia 2004–2013: A Population-Based Study [2016]
• Canada
  • Current Oncology
    • Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update [2016]
    • The changing landscape of brachytherapy for cervical cancer: a Canadian practice survey [2015]
  • Ontario Health
    • Three-Dimensional MR-Guided Intracavitary and Interstitial Brachytherapy for Cervical Cancer [2017]
    • Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation [2016]
• China
  • BMC Cancer
    • Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016 [2021]
  • Frontiers in Oncology
    • Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021 [2021]
• Denmark
  • BJOG: An International Journal of Obstetrics & Gynaecology
    • Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study [2020]
  • Gynecologic Oncology
    • Cervical cancer survivors and health care use: A Danish population-based register study [2021]
• Europe
  • European Organisation for Research and Treatment of Cancer
    • Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer—Gynecological Cancer Group (EORTC-GCG) [2009]
  • European Society for Gynaecological Endoscopy
    • The role of minimally invasive radical hysterectomy for cervical cancer: ESGE-SERGS position document and joint-statement [2020]
  • European Society for Medical Oncology
    • eUpdate – Cervical Cancer Treatment Recommendations [2020]
  • European Society of Gynaecological Oncology
    • European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer [2020]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Aspects of Therapy for Cervical Cancer in Germany 2012 – Results from a Survey of German Gynaecological Hospitals [2013]
• India
  • Journal of Cancer Research and Therapeutics
    • Literature review with PGI guidelines for delineation of clinical target volume for intact carcinoma cervix [2013]
  • Journal of Contemporary Brachytherapy
    • Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy [2019]
• International
  • European Association of Nuclear Medicine
    • EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0 [2021]
  • International Atomic Energy Agency
    • Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives [2020]
  • International Journal of Radiation Oncology
    • Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer [2014]
  • JAMA Network Open
    • Red Blood Cell Transfusion Practices for Patients With Cervical Cancer Undergoing Radiotherapy [2021]
  • JCO Global Oncology
    • Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population [2021]
  • Radiotherapy and Oncology
    • IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer [2021]
• Japan
  • Chinese Journal of Cancer Research
    • Adjuvant chemotherapy for early-stage cervical cancer [2016]
  • Gynecologic Oncology
    • Fertility-sparing trachelectomy for early-stage cervical cancer: A proposal of an ideal candidate [2020]
  • Japanese Journal of Clinical Oncology
    • A Consensus-based Guideline Defining the Clinical Target Volume for Pelvic Lymph Nodes in External Beam Radiotherapy for Uterine Cervical Cancer [2010]
  • Journal of Gynecologic Oncology
    • The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee [2021]
    • Quality indicators for cervical cancer care in Japan [2018]
  • Journal of Radiation Research
    • Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients [2017]
    • A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan [2015]
• Low and middle income countries
  • Gynecologic Oncology Reports
    • Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery [2017]
• Low-resource settings
  • International Atomic Energy Agency
    • Management of Cervical Cancer: Strategies for Limited-resource Centres - A Guide for Radiation Oncologists [2013]
• Netherlands
  • European Journal of Cancer
    • Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature review [2020]
• Poland
  • PLoS ONE
    • Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations [2019]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06) [2021]
    • Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement [2019]
    • Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer [2015]
  • PLoS ONE
    • Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation [2018]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of histologically confirmed cervical cancer [2021]
• Sub-Saharan Africa
  • Oncologist
    • Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence [2021]
• United Kingdom
  • Healthcare Improvement Scotland
    • Cervical Cancer Clinical Quality Performance Indicators [2016]
  • National Institute for Health and Care Excellence
    • Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer [2023]
    • Minimally invasive radical hysterectomy for early stage cervical cancer [2021]
    • Topotecan for the treatment of recurrent carcinoma of the cervix [2009]
  • Royal College of Obstetricians and Gynaecologists
    • Reproductive Outcomes after Local Treatment for Preinvasive Cervical Disease [2016]
• United States
  • American College of Obstetricians and Gynecologists
    • Updated Guidelines for Management of Cervical Cancer Screening Abnormalities [2020]
  • American College of Radiology
    • Role of adjuvant therapy in the management of early stage cervical cancer
  • American Society of Clinical Oncology
    • Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update [2022]
    • Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline [2016]
    • Management and Care of Women With Invasive Cervical Cancer Resource-Stratified Guideline
  • Gynecologic Oncology
    • Cervical Excisional Treatment of Young Women: A Population-based Study [2014]
  • National Cancer Institute
    • Cervical Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines Insights: Cervical Cancer, Version 1.2020 [2020]
  • OncoTargets and therapy
    • Profile of bevacizumab and its potential in the treatment of cervical cancer [2015]
  • Society of Gynecologic Oncology
    • SGO member update: Emerging data on the surgical approach for radical hysterectomy in the treatment of women with cervical cancer [2019]
• WHO
  • World Health Organization
    • Technical specifications of radiotherapy equipment for cancer treatment [2021]
    • WHO framework for strengthening and scaling-up services for the management of invasive cervical cancer [2020]
    • WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions [2019]
    • Treatment of cervical intraepithelial neoplasia 2–3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization [2014]
    • Cryosurgical equipment for the treatment of precancerous cervical lesions and prevention of cervical cancer [2012]
    • WHO guidelines: use of cryotherapy for cervical intraepithelial neoplasia [2011]
    • Treating invasive cervical cancer
• {Related topics}
  • Guidelines
    • Cervical cancer

Cervical cancer: vaccine

• Africa, Asia
  • Asian Pacific Journal of Cancer Prevention
    • Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis [2021]
• Americas
  • Centers for Disease Control and Prevention
    • Progress Toward Implementation of Human Papillomavirus Vaccination --- the Americas, 2006--2010 [2011]
  • Pan American Health Organization
    • Methodology to calculate HPV Vaccine Coverage in the Region of the Americas [2019]
• Australia
  • Australian Family Physician
    • Abnormal Pap tests after the HPV vaccine [2009]
  • Australian Institute of Health and Welfare
    • HPV immunisation rates 2015–16 [2018]
  • Australian Journal of General Practice
    • Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule [2018]
  • Department of Health and Aged Care
    • Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia [2020]
    • Human papillomavirus (HPV) | The Australian Immunisation Handbook [2018]
  • EuroSurveillance
    • The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? [2018]
  • Lancet Public Health
    • Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis [2016]
  • PLoS ONE
    • Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia [2018]
• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Guidelines for HPV vaccine [2019]
• Austria
  • BMC Infectious Diseases
    • Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria [2016]
• Botswana
  • Centers for Disease Control and Prevention
    • Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project — Botswana, 2013 [2015]
• Brazil
  • Revista Panamericana de Salud Pública
    • Paving pathways: Brazil's implementation of a national human papillomavirus immunization campaign [2015]
• Canada
  • BMC Infectious Diseases
    • Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis [2011]
  • Canadian Family Physician
    • Effect of human papillomavirus vaccination on sexual behaviour among young females [2018]
    • Update on the new 9-valent vaccine for human papillomavirus prevention [2016]
    • HPV vaccine for cancer and wart prevention [2015]
  • Canadian Paediatric Society
    • Human papillomavirus vaccine for children and adolescents [2018]
  • Government of Canada
    • Human Papillomavirus Vaccine
  • Public Health Agency of Canada
    • Updated Recommendations on Human Papillomavirus Vaccines: 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule [2016]
    • Update On Human Papillomavirus (HPV) Vaccines [2012]
• Caribbean
  • Pan American Health Organization
    • HPV Vaccination: Toward the Elimination of Cervical Cancer in the Caribbean Countries. Virtual Meeting Report, 22–23 and 29–30 October 2020 [2021]
• Chile
  • BMC Public Health
    • Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model [2014]
• China
  • BMC Infectious Diseases
    • Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China [2017]
  • BMC Public Health
    • Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies [2016]
  • Human Vaccines & Immunotherapeutics
    • Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women [2021]
  • Preventive Medicine
    • A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China [2021]
• Denmark
  • Acta Obstetricia et Gynecologica Scandinavica
    • High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study [2020]
  • International Journal of Cancer
    • Prevalence of high-risk human papillomavirus after HPV-vaccination in Denmark [2020]
• Developing countries
  • Infectious Diseases in Obstetrics and Gynecology
    • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries [2011]
• Estonia
  • BMC Infectious Diseases
    • The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia [2013]
• Europe
  • Cancer Medicine
    • HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level [2019]
  • European Centre for Disease Prevention and Control
    • Human papillomavirus
  • European Society of Gynaecological Oncology
    • Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy [2019]
  • EuroSurveillance
    • Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma [2021]
  • WHO Regional Office for Europe
    • Communicating with caregivers about the Human Papillomavirus vaccination: facilitator’s guide [2023]
    • Communicating with caregivers about the Human Papillomavirus vaccination: a tool to build confidence in communication skills among health workers [2023]
• Fiji
  • BMC Public Health
    • Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents [2015]
• France
  • Human Vaccines & Immunotherapeutics
    • Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history [2015]
    • A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France [2013]
• Greece
  • In Vivo
    • Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study [2020]
• High-income countries
  • BMC Public Health
    • Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis [2014]
  • Lancet
    • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [2019]
• Hong Kong
  • PLoS ONE
    • Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents [2018]
• India
  • Asian Pacific Journal of Cancer Prevention
    • HPV Vaccination of Girl Child in India: Intervention for Primary Prevention of Cervical Cancer [2018]
  • ISRN Obstetrics and Gynecology
    • HPV Vaccination in India: Critical Appraisal [2014]
• Indonesia
  • PLoS ONE
    • Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis [2020]
• International
  • International Papillomavirus Society
    • IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity” [2020]
  • Lancet Public Health
    • Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis [2021]
  • Preventive Medicine Reports
    • Cost and effectiveness of HPV vaccine delivery strategies: A systematic review [2022]
• Iran
  • Intervirology
    • Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines [2017]
• Japan
  • Cancer Science
    • A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan [2021]
    • Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program [2019]
  • Human Vaccines & Immunotherapeutics
    • Changing trends in HPV vaccination in Japan [2022]
    • Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods [2021]
  • Lancet Regional Health: Western Pacific
    • The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine [2021]
    • Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data [2021]
  • Scientific Reports
    • Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine [2020]
    • Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year [2018]
  • Vaccines
    • Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program [2022]
• Kenya
  • EClinicalMedicine
    • Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence [2022]
• Low and middle income countries
  • BMC Health Services Research
    • Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014 [2016]
  • JNCI Cancer Spectrum
    • Human Papillomavirus Vaccination After COVID-19 [2021]
  • Vaccine
    • Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects [2013]
• Luxembourg
  • Cancer Epidemiology
    • Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg [2019]
• Malaysia
  • BMC Public Health
    • Cost- effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia [2016]
• Middle East, North Africa
  • Eastern Mediterranean Health Journal
    • Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review [2018]
• Netherlands
  • International Journal of Cancer
    • Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer [2021]
• New Zealand
  • Ministry of Health New Zealand
    • Revitalising the National HPV Immunisation Programme [2015]
    • HPV Immunisation Programme Implementation Evaluation [2012]
• Nigeria
  • BMC Health Services Research
    • Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage [2017]
• Norway
  • BMC Public Health
    • Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway [2021]
  • PLoS ONE
    • Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys [2014]
  • Preventive Medicine
    • Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents [2015]
• PAHO
  • Pan American Health Organization
    • Human Papillomavirus (HPV) Vaccine
• Peru
  • PLoS ONE
    • Parental Acceptance of HPV Vaccine in Peru: A Decision Framework [2012]
• Philippines
  • BMC Public Health
    • A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines [2015]
  • Cost Effectiveness and Resource Allocation
    • Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer? [2018]
• Republic of Korea
  • International Journal of Environmental Research and Public Health
    • Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review [2021]
  • Journal of Gynecologic Oncology
    • Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines [2021]
    • Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline [2019]
    • Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline [2016]
  • Virology Journal
    • Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study [2021]
• Singapore
  • Society for Colposcopy and Cervical Pathology of Singapore
    • SCCPS Scientific Committee Position Paper on HPV Vaccination [2020]
• South Africa
  • BMC Infectious Diseases
    • Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence [2015]
• Spain
  • EuroSurveillance
    • Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 [2019]
• Sub-Saharan Africa
  • PLoS ONE
    • Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review [2014]
• Sweden
  • American Journal of Epidemiology
    • Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs [2021]
  • Archives of Gynecology and Obstetrics
    • Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008–2018, and perspectives on cancer prevention [2021]
  • British Journal of Cancer
    • Impact of HPV vaccination on cervical screening performance: a population-based cohort study [2020]
• Switzerland
  • BMC Infectious Diseases
    • Impact of HPV vaccination with Gardasil® in Switzerland [2017]
  • BMC Public Health
    • Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland [2020]
• Tanzania
  • Health Policy and Planning
    • Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania [2016]
• Thailand
  • PLoS ONE
    • The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand [2021]
• Uganda
  • Infectious Agents and Cancer
    • Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review [2011]
  • Vaccine
    • Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country [2018]
• United Kingdom
  • BMC Infectious Diseases
    • Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK [2019]
  • BMJ
    • Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [2019]
  • HSC Public Health Agency
    • Human papillomavirus (HPV) immunisation programme - Factsheet for healthcare professionals [2022]
  • Human Vaccines & Immunotherapeutics
    • Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom [2015]
  • PLoS ONE
    • HPV Serology Testing Confirms High HPV Immunisation Coverage in England [2016]
  • Public Health Scotland
    • HPV immunisation statistics Scotland
    • HPV education pack
  • UK Health Security Agency
    • Human papillomavirus (HPV): the green book, chapter 18a
    • HPV vaccination programme
  • Vaccine
    • Risk of spontaneous abortion and other pregnancy outcomes in 15–25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom [2015]
• United States
  • American Cancer Society
    • Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation [2020]
    • Guidelines for Human Papillomavirus Vaccine Use
  • American College of Obstetricians and Gynecologists
    • Human Papillomavirus Vaccination [2020]
  • American Society of Clinical Oncology
    • Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline [2017]
    • American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention [2016]
    • Primary Prevention of Cervical Cancer Resource-Stratified Guideline
  • BMC Pediatrics
    • Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008–2012 [2017]
  • Cancer Epidemiology Biomarkers & Prevention
    • Disparities in healthcare providers’ recommendation of HPV vaccination for US adolescents: A systematic review [2021]
    • Assessing Impact of HPV Vaccination on Cervical Cancer Incidence in Women 15–29 years in the United States, 1999–2017: An Ecologic Study [2021]
  • Centers for Disease Control and Prevention
    • Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018 [2021]
    • Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices [2019]
    • Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices [2016]
    • Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices [2015]
    • Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans — United States, 2013 [2015]
    • National Human Papillomavirus Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey – Teen, United States, 2011 [2014]
    • Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [2014]
    • Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States [2014]
    • CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease [2014]
    • Surveillance Manual | HPV
    • Safety Information for HPV Vaccine
    • HPV Vaccine Schedule and Dosing
    • HPV Vaccination | For Providers
  • Food and Drug Administration
    • Gardasil
  • Frontiers in Oncology
    • Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination [2016]
  • Human Vaccines & Immunotherapeutics
    • Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13–17 by metropolitan statistical area (MSA) status, National Immunization Survey – Teen, 2013 – 2017 [2020]
    • Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature [2019]
    • Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule [2015]
  • International Journal of Cancer
    • Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening [2020]
  • JAMA Network Open
    • Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women [2019]
  • National Cancer Institute
    • Human Papillomavirus (HPV) Vaccines
  • Obstetrics & Gynecology Clinics of North America
    • Human Papillomavirus Vaccination: Current Indications and Future Directions [2013]
  • Preventive Medicine Reports
    • Obstetrician/gynecologists’ HPV vaccination recommendations among women and girls 26 and younger [2022]
    • Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists [2022]
  • Society for Adolescent Health and Medicine
    • Human Papillomavirus (HPV) Vaccine: A Position Statement of the Society for Adolescent Medicine [2006]
  • Vaccine
    • Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis [2021]
    • Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014) [2019]
    • Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers [2014]
  • Vaccines
    • Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019–2020 [2022]
• Western Pacific
  • Vaccines
    • A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region [2021]
• WHO
  • International Agency for Research on Cancer
    • Protection from a Single Dose of HPV Vaccine [2023]
  • World Health Organization
    • User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (C4P-HPV tool) [2023]
    • Human papillomavirus vaccines: WHO position paper, May 2022 [2022]
    • Global market study: HPV vaccines [2022]
    • Human papillomavirus (HPV) vaccine coverage monitoring manual [2020]
    • HPV Vaccine Coverage Monitoring Manual [2020]
    • Scaling-up HPV vaccine introduction [2016]
    • HPV vaccine communication: special considerations for a unique vaccine. 2016 update [2016]
    • Guide to introducing HPV vaccine into national immunization programmes [2016]
    • The immunological basis for immunization series: module 19: human papillomavirus infection [2011]
    • Report of the meeting on HPV vaccine coverage and impact monitoring, 16-17 November 2009, Geneva, Switzerland [2010]
    • Cervical cancer, human papillomavirus (HPV) and HPV vaccines : key points for policy-makers and health professionals [2007]
    • Immunizing against HPV
    • Girls aged 15 years old that received the recommended doses of HPV vaccine
• Zimbabwe
  • Infectious Agents and Cancer
    • Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe [2014]
• {Related topics}
  • Guidelines
    • Genital warts, HPV vaccine for men
    • Cervical cancer: screening, prevention
    • Cervical cancer

Endometrial cancer

• Australasia
  • Royal College of Pathologists of Australasia
    • Uterus endometrial and myometrial malignancies
• Australia
  • Cancer Australia
    • Shared follow-up care for women with low-risk endometrial cancer: A guide for General Practitioners [2020]
    • Shared follow-up and survivorship care for women with low-risk endometrial cancer: summary of evidence [2020]
    • Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer [2020]
    • Shared follow-up and survivorship care for low-risk endometrial cancer: Roles and responsibilities for the delivery of care [2020]
    • Risk Factors for Endometrial Cancer - A review of the evidence 2019 [2019]
    • Follow-up care for women with low-risk endometrial cancer: A guide for General Practitioners 2017 [2017]
    • Report to the nation - Uterine cancer 2012 [2012]
• Brazil
  • Revista da Associação Médica Brasileira
    • Endometrial carcinoma: treatment [2012]
• Canada
  • BC Cancer Agency
    • Endometrium
  • BCGuidelines
    • Genital Tract Cancers in Females: Endometrial Cancer [2014]
  • Canadian Agency for Drugs and Technologies in Health
    • Trastuzumab Combination and Monotherapy for HER2 Advanced or Recurrent Uterine or Endometrial Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness [2020]
  • Canadian Cancer Society
    • Uterine cancer
  • Ontario Health
    • Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma [2019]
    • Follow-up After Primary Therapy for Endometrial Cancer [2017]
  • Society of Obstetricians and Gynaecologists of Canada
    • Epidemiology and Investigations for Suspected Endometrial Cancer [2018]
• Denmark
  • BMJ
    • Pregnancy duration and endometrial cancer risk: nationwide cohort study [2019]
• Europe
  • Cancers
    • Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists [2022]
  • European Society for Medical Oncology
    • ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer [2016]
    • Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2013]
  • European Society of Gynaecological Oncology
    • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma [2021]
• France
  • Journal of Gynecologic Oncology
    • Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group [2019]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) – Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer [2018]
    • Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) – Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities [2018]
  • Journal of Cancer Research and Clinical Oncology
    • Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma [2009]
• International
  • British Journal of Cancer
    • Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2) [2015]
  • Frontiers in Oncology
    • Global, Regional, and National Burden of Endometrial Cancer, 1990–2017: Results From the Global Burden of Disease Study, 2017 [2019]
  • Human Reproduction Update
    • Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis [2022]
  • International Collaboration on Cancer Reporting
    • Endometrial Cancers [2021]
  • International Federation of Gynecology and Obstetrics
    • Cancer of the corpus uteri: 2021 update [2021]
    • Role of imaging in the routine management of endometrial cancer [2018]
    • Cancer of the corpus uteri [2018]
  • International Society of Gynecological Pathologists
    • Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists [2019]
    • International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group [2019]
    • High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations [2019]
    • Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists [2019]
    • Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists [2019]
    • Current Practices in the Processing, Diagnosis, and Reporting of Endometrial Carcinoma: Results of a Web-based Survey by the International Society of Gynecological Pathologists (ISGyP) [2019]
  • Obstetrics & Gynecology Science
    • Fertility-sparing treatment in early endometrial cancer: current state and future strategies [2020]
• Israel
  • Cancer
    • Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers [2019]
• Italy
  • Frontiers in Oncology
    • Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group [2022]
• Japan
  • Journal of Gynecologic Oncology
    • Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee [2017]
  • Tohoku Journal of Experimental Medicine
    • Efficient Screening Strategy for Lynch Syndrome in Japanese Endometrial Cancer [2015]
• Netherlands
  • Cancers
    • Endometrial Cancer Incidence in Endometriosis and Adenomyosis [2021]
  • Gynecologic Oncology
    • Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer [2021]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement [2017]
  • Oncotarget
    • Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study [2017]
• Romania
  • Journal of Medicine and Life
    • Project for the National Program of Early Diagnosis of Endometrial Cancer Part II [2015]
    • Project for the National Program of Early Diagnosis of Endometrial Cancer Part I [2015]
    • Evaluation of endometrial cancer epidemiology in Romania [2015]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for the Systemic Therapy of Endometrial (Uterine) Cancer [2015]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM-GEICO clinical guidelines on endometrial cancer (2021) [2022]
    • SEOM clinical guidelines for endometrial cancer (2017) [2018]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of histologically confirmed endometrial cancer [2021]
• Sweden
  • BMC Cancer
    • Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study [2021]
  • International Journal of Cancer
    • Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group [2017]
• Taiwan
  • PLoS ONE
    • Nationwide Surveillance in Uterine Cancer: Survival Analysis and the Importance of Birth Cohort: 30-Year Population-Based Registry in Taiwan [2012]
• United Kingdom
  • BMJ Open
    • Economic evaluation of different routes of surgery for the management of endometrial cancer: a retrospective cohort study [2021]
    • Surgical trends, outcomes and disparities in minimal invasive surgery for patients with endometrial cancer in England: a retrospective cohort study [2020]
  • Cancer Research UK
    • Uterine cancer statistics
  • Healthcare Improvement Scotland
    • Endometrial Cancer Clinical Quality Performance Indicators [2016]
  • National Institute for Health and Care Excellence
    • Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency [2022]
    • Testing strategies for Lynch syndrome in people with endometrial cancer [2020]
    • Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer [2010]
    • Endometrial cancers
  • Royal College of Obstetricians and Gynaecologists
    • Endometrial Cancer in Obese Women [2012]
  • Royal College of Pathologists
    • Dataset for histopathological reporting of endometrial cancer [2017]
• United States
  • American College of Obstetricians and Gynecologists
    • Endometrial Intraepithelial Neoplasia [2015]
    • Tamoxifen and Uterine Cancer [2014]
  • American College of Radiology
    • ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer [2016]
    • Pretreatment Evaluation and Follow-Up of Endometrial Cancer
    • Management of Recurrent Endometrial Cancer
    • Advanced stage endometrial cancer
  • American Family Physician
    • Diagnosis and Management of Endometrial Cancer [2016]
  • American Journal of Obstetrics & Gynecology
    • Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment [2020]
  • American Society for Radiation Oncology
    • An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method [2016]
    • The role of postoperative radiation therapy for endometrial cancer: Executive Summary of an American Society for Radiation Oncology evidence-based guideline [2014]
  • American Society of Clinical Oncology
    • Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline [2015]
    • Postoperative Radiation Therapy for Endometrial Cancer Endorsement
  • CA: A Cancer Journal for Clinicians
    • Current recommendations and recent progress in endometrial cancer [2019]
  • Cancer Epidemiology Biomarkers & Prevention
    • The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women [2015]
  • Centers for Disease Control and Prevention
    • Uterine Cancer Incidence and Mortality — United States, 1999–2016 [2018]
    • Uterine Cancer
  • Ethnicity & Disease
    • The Impact of Fibroids and Histologic Subtype on the Performance of US Clinical Guidelines for the Diagnosis of Endometrial Cancer among Black Women [2020]
  • European Journal of Epidemiology
    • Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947–1964: The Nurses’ Health Study II, a prospective cohort study [2021]
  • Gynecologic Oncology
    • Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer [2020]
    • National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer [2019]
    • Disparities in Uterine Cancer Epidemiology, Treatment, and Survival Among African Americans in the United States [2013]
  • In Vivo
    • Controversies in the Management of Early-stage Serous Endometrial Cancer [2021]
  • International Journal of Cancer
    • Guideline-concordant endometrial cancer treatment and survival in the Women’s Health Initiative Life and Longevity After Cancer study [2020]
  • Journal of Gynecologic Oncology
    • Management of stage II endometrial cancer and subsequent oncologic outcomes: a National Cancer Database study [2020]
  • M.D. Anderson Cancer Center
    • Endometrial Cancer
  • National Cancer Institute
    • Uterine Cancer
    • Endometrial Cancer Treatment (PDQ®)
    • Endometrial Cancer Screening (PDQ®)
    • Endometrial Cancer Prevention (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021 [2021]
    • Uterine Neoplasms
  • OncoLink
    • Endometrial and Uterine Cancer
  • Oncologist
    • Adjuvant Therapy in Early-Stage Endometrial Cancer: A Systematic Review of the Evidence, Guidelines, and Clinical Practice in the U.S. [2014]
  • Society of Gynecologic Oncology
    • Sentinel Lymph Node Mapping and Staging in Endometrial Cancer: A Society of Gynecologic Oncology Literature Review with Consensus Recommendations [2017]
    • SGO Clinical Practice Statement: The Role of Sentinel Lymph Node Mapping in Endometrial Cancer [2015]
    • SGO Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer [2014]
    • Endometrial cancer: A review and current management strategies: Part II [2014]
    • Endometrial cancer: A review and current management strategies: Part I [2014]
• WHO
  • International Agency for Research on Cancer
    • Corpus uteri fact sheet
  • World Health Organization
    • Corpus uteri cancer
• {Related topics}
  • Guidelines
    • Gynecologic oncology

Gynecologic oncology

• Asia
  • Journal of Gynecologic Oncology
    • Asian Society of Gynecologic Oncology International Workshop 2018 [2019]
• Asia, Oceania
  • Asia and Oceania Federation of Obstetrics and Gynaecology
    • COVID-19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion [2021]
• Australasia
  • Royal College of Pathologists of Australasia
    • Ovary and fallopian tube - malignant setting
• Australia
  • Cancer Australia
    • Gynaecological cancers: a handbook for Aboriginal and Torres Strait Islander Health Workers and Health Practictioners [2018]
    • Gynaecological cancers update 2017 [2017]
    • National Framework for Gynaecological Cancer Control [2016]
    • Report to the nation - cancers of the vagina, vulva and other female genital organs and placenta 2012 [2012]
• Belarus
  • International Agency for Research on Cancer
    • Current Status and Future Direction of Breast and Cervical Cancer Prevention and Management in Belarus [2012]
• Belgium
  • BMC Health Services Research
    • The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia [2018]
• Canada
  • BC Cancer Agency
    • Gynecology
  • BCGuidelines
    • Genital Tract Cancers in Females: Human Papillomavirus Related Cancers (Cervical, Vaginal & Vulvar) [2016]
    • Genital Tract Cancers in Females: Ovarian, Fallopian Tube, and Primary Peritoneal Cancers [2014]
  • Canadian Family Physician
    • Cancer screening in Canada. What’s in, what’s out, what’s coming [2021]
  • Ontario Health
    • Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma [2021]
    • An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma [2021]
  • Society of Obstetricians and Gynaecologists of Canada
    • Initial Investigation and Management of Adnexal Masses [2020]
    • Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population [2017]
• China
  • BMC Cancer
    • A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities [2020]
  • BMC Women's Health
    • Women’s cancers in China: a spatio-temporal epidemiology analysis [2021]
  • Journal of Gynecologic Oncology
    • Epidemiology of gynecologic cancers in China [2018]
• Colombia
  • BMC Cancer
    • Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis [2020]
• Croatia
  • Croatian Medical Journal
    • Breast and gynecological cancers in Croatia, 1988-2008 [2012]
• Denmark
  • Acta Obstetricia et Gynecologica Scandinavica
    • Ovarian and tubal cancer in Denmark: an update on incidence and survival [2016]
• Europe
  • Cancers
    • GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors—Current Challenges and Future Directions [2021]
  • European Society for Medical Oncology
    • ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies [2020]
  • European Society of Gynaecological Oncology
    • Quality indicators - Cervical, ovarian, vulvar cancers [2019]
  • Society of European Robotic Gynaecological Surgery
    • Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS) [2020]
• France
  • Archive ouverte HAL
    • Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2 systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up) [2019]
    • Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1 Diagnostic exploration and staging, surgery, perioperative care, and pathology [2019]
  • BMC Cancer
    • Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey [2016]
  • BMC Health Services Research
    • Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: what remains to be achieved by French national programmes? [2014]
  • Journal of Gynecology Obstetrics and Human Reproduction
    • Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF [2020]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Statement of the AGO and AG-CPC on the Aftercare/Follow-up for Surgical Procedures of the Lower Genital Tract after the Introduction of a New Cancer Screening Guideline [2020]
• Ghana
  • BMC Women's Health
    • Self-reported breast and cervical cancer screening practices among women in Ghana: predictive factors and reproductive health policy implications from the WHO study on global AGEing and adult health [2020]
• India
  • BMC Women's Health
    • An epidemiological study of cervical and breast screening in India: district-level analysis [2020]
  • Cancer Epidemiology
    • Trends in breast and cervical cancer in India under National Cancer Registry Programme: An Age-Period-Cohort analysis [2021]
  • South Asian Journal of Cancer
    • Gynecological cancers: A summary of published Indian data [2016]
• International
  • Annals of Oncology
    • Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting [2019]
  • Biomarker Research
    • Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study [2021]
  • Current Oncology
    • Outcomes of Enhanced Recovery after Surgery (ERAS) in Gynecologic Oncology: A Review [2022]
  • Enhanced Recovery After Surgery
    • Enhanced recovery after surgery (ERAS®) in gynecologic oncology – Practical considerations for program development [2017]
    • Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part I [2016]
    • Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part II [2016]
  • Geburtshilfe und Frauenheilkunde
    • 2020 WHO Classification of Female Genital Tumors [2021]
  • Gynecologic Cancer Intergroup
    • Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions [2019]
    • GCIG Consensus Review: Uterine and Ovarian Leiomyosarcomas [2014]
  • Gynecologic Oncology
    • Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: A systematic review and network meta-analysis [2021]
    • Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations [2020]
  • International Collaboration on Cancer Reporting
    • Ovary, Fallopian Tube and Primary Peritoneal Carcinomas [2021]
  • International Federation of Gynecology and Obstetrics
    • Progress in the pathological arena of gynecological cancers [2021]
    • Obesity and gynecological cancers: A toxic relationship [2021]
    • Cancer of the ovary, fallopian tube, and peritoneum: 2021 update [2021]
    • COVID-19 and the impact on gynecologic cancer care [2021]
    • Targeted therapy for gynecologic cancers: Toward the era of precision medicine [2018]
    • Surgical pelvic anatomy in gynecologic oncology [2018]
    • Pathology of cancers of the female genital tract including molecular pathology [2018]
    • Palliative care in women's cancer care: Global challenges and advances [2018]
    • FIGO Cancer Report 2018 [2018]
    • Essential surgical skills for a gynecologic oncologist [2018]
    • Enhanced recovery after surgery in gynecologic oncology [2018]
    • Cancer of the ovary, fallopian tube, and peritoneum [2018]
    • Cancer in pregnancy [2018]
    • The future role of molecular staging in gynecologic cancer [2015]
    • Rehabilitation after gynecological cancer treatment [2015]
    • Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer [2015]
    • Principles of chemotherapy [2015]
    • FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication [2015]
  • International Journal of Cancer
    • Geographic and temporal variations in the incidence of vulvar and vaginal cancers [2020]
  • International Journal of Gynecological Pathology
    • Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites [2019]
• Israel
  • Annals of Family Medicine
    • Socioeconomic Disparity Trends in Cancer Screening Among Women After Introduction of National Quality Indicators [2021]
• Japan
  • International Journal of Clinical Oncology
    • Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer [2018]
  • Journal of Gynecologic Oncology
    • The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer [2021]
    • Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms [2019]
    • Clinical statistics of gynecologic cancers in Japan [2017]
• Lithuania
  • Medicina
    • Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016 [2020]
• Low and middle income countries
  • Asian Pacific Journal of Cancer Prevention
    • Barriers to Cervical Cancer and Breast Cancer Screening Uptake in Low-Income and Middle-Income Countries: A Systematic Review [2017]
  • PLoS ONE
    • Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries [2015]
• Low-resource settings
  • International Federation of Gynecology and Obstetrics
    • Reaching the women with the greatest needs: Two models for initiation and scale-up of gynecologic oncology fellowship trainings in low-resource settings [2021]
• Malawi
  • BMC Cancer
    • Breast and cervical cancer screening services in Malawi: a systematic review [2020]
• Netherlands
  • Journal of Gynecologic Oncology
    • Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands [2020]
• New Zealand
  • Ministry of Health New Zealand
    • Me aro ki te ha o Hineahuone – a national evaluation of breast and cervical Screening Support Services [2021]
    • Gynaecologic Cancer Follow-up: New Zealand Gynaecological Cancer Group guidelines [2015]
• Nordic countries
  • BMC Cancer
    • Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment [2022]
• Poland
  • Clinical Epidemiology
    • Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018) [2022]
  • OncoTargets and therapy
    • Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socioeconomic changes [2016]
  • Przeglad Menopauzalny = Menopause Review
    • Clinical practice recommendations for quality of life assessment in patients with gynecological cancer [2015]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database [2020]
    • Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015 [2019]
    • Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers [2016]
    • Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy [2016]
    • Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010 [2013]
  • Obstetrics & Gynecology Science
    • Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology [2022]
    • The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry [2021]
• South Africa
  • Asian Pacific Journal of Cancer Prevention
    • Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population [2018]
• Sub-Saharan Africa
  • Gynecologic Oncology
    • A scoping review: Facilitators and barriers of cervical cancer screening and early diagnosis of breast cancer in Sub-Saharan African health settings [2020]
• Sudan
  • Cancer Medicine
    • Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers [2015]
• Sweden
  • BMC Cancer
    • Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study [2021]
• Switzerland
  • BMC Cancer
    • 40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland [2015]
• Thailand
  • Journal of Gynecologic Oncology
    • The epidemiologic status of gynecologic cancer in Thailand [2016]
• Turkey
  • Journal of Gynecologic Oncology
    • Survival of gynecological cancers in Turkey: where are we at? [2017]
• United Kingdom
  • BMC Cancer
    • Incidence of breast and gynaecological cancers by ethnic group in England, 2001–2007: a descriptive study [2014]
  • BMC Public Health
    • The costs of treating vaginal and vulval cancer in England (2009–2015) [2020]
  • BMJ
    • Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation [2018]
  • British Gynaecological Cancer Society
    • COVID19 Resources
  • British Journal of Cancer
    • Occupational cancer in Britain [2012]
  • National Institute for Health and Care Excellence
    • Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer [2022]
    • Olaparib plus bevacizumab for maintenance treatment of advanced ovarian, fallopian tube or primary peritoneal cancer [2021]
    • Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [2021]
    • Olaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer [2020]
    • Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer [2019]
    • Bevacizumab for treating relapsed, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal) [2015]
  • Royal College of Pathologists
    • Dataset for histopathological reporting of carcinomas and borderline tumours of the ovaries, fallopian tubes and peritoneum [2019]
• United States
  • Abdominal Radiology
    • Gynecologic tumor board: a radiologist’s guide to vulvar and vaginal malignancies [2021]
  • American Journal of Clinical Dermatology
    • Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients [2020]
  • American Society of Clinical Oncology
    • Gynecologic Cancer
  • Asian Nursing Research
    • Cultural Factors Associated with Breast and Cervical Cancer Screening in Korean American Women in the US: An Integrative Literature Review [2015]
  • BMC Public Health
    • A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States [2014]
  • Cancer
    • The National Breast and Cervical Cancer Early Detection Program: Toward a system of cancer screening in the United States [2014]
    • National Breast and Cervical Cancer Early Detection Program partnerships in action [2014]
    • Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs [2008]
  • Cancer Epidemiology Biomarkers & Prevention
    • A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States [2008]
  • Centers for Disease Control and Prevention
    • National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
    • Gynecologic Cancers
  • Frontiers in Oncology
    • Disparities in Gynecological Malignancies [2016]
  • Gynecologic Oncology
    • Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies [2012]
  • Gynecologic Oncology Reports
    • Temporal trends and characteristics of suicide among women with gynecologic malignancy in the United States [2019]
  • International Journal of Environmental Research and Public Health
    • Health Care Access Measures and Palliative Care Use by Race/Ethnicity among Metastatic Gynecological Cancer Patients in the United States [2021]
  • Journal of General Internal Medicine
    • Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines [2015]
  • M.D. Anderson Cancer Center
    • Gynecologic Oncology Center
  • National Cancer Institute
    • Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)
    • Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ®)
    • Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)
    • Childhood Cervical and Vaginal Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer
  • OncoLink
    • Gynecologic Cancers
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States [2021]
  • Society of Gynecologic Oncology
    • When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic [2020]
    • Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement [2020]
    • Society of gynecologic oncology surgery considerations during when to operate, hesitate and reintegrate the COVID-19 pandemic [2020]
    • Anti-cancer Therapy and Clinical Trial Considerations for Gynecologic Oncology Patients During the COVID-19 Pandemic Crisis [2020]
    • The “value” of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations [2017]
    • Opioid Use in Gynecologic Oncology; Balancing Efficacy, Accessibility and Safety: An SGO Clinical Practice Statement [2017]
    • An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations [2017]
    • Improving quality and decreasing cost in gynecologic oncology care: Society of Gynecologic Oncology recommendations for clinical practice [2015]
    • Comprehensive care in gynecologic oncology: The importance of palliative care [2015]
  • U.S. Department of Veterans Affairs
    • Evidence Brief: Accuracy of Self-report for Cervical and Breast Cancer Screening [2019]
• {Related topics}
  • Guidelines
    • Vulvar cancer
    • Vaginal cancer
    • Uterine sarcoma
    • Tubal cancer
    • Trophoblastic neoplasms
    • Ovarian cancer
    • Hereditary gynecologic cancer, genetic predisposition
    • Gynecologic surgery
    • Fertility preservation
    • Endometrial cancer
    • Cervical cancer
    • Breast cancer

Hereditary gynecologic cancer, genetic predisposition

• Arab countries
  • BMC Cancer
    • Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis [2019]
• Australia
  • Hereditary Cancer in Clinical Practice
    • Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice [2021]
  • Medical Services Advisory Committee
    • Testing of tumour tissue or blood to detect somatic or germline BRCA1 or BRCA2 gene mutations, in a patient with newly diagnosed, advanced (FIGO stage III-IV) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) to first-line platinum-based chemotherapy) [2020]
    • Genetic testing for hereditary mutations predisposing to cancer (breast and/or ovarian) [2016]
• Austria
  • Archives of Gynecology and Obstetrics
    • AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS) [2017]
• Brazil
  • JCO Global Oncology
    • Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil [2020]
• Canada
  • Ontario Health
    • Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline [2021]
  • Society of Obstetricians and Gynaecologists of Canada
    • Gynaecologic Management of Hereditary Breast and Ovarian Cancer [2018]
• Caribbean
  • JAMA Network Open
    • Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean [2021]
• Europe
  • European Molecular Genetics Quality Network
    • A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories [2017]
  • European Society for Medical Oncology
    • Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening [2016]
• France
  • Cancers
    • TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing [2021]
  • Frontiers in Oncology
    • GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers [2018]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer [2020]
• India
  • JCO Global Oncology
    • Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology [2020]
• International
  • Breast Cancer Research and Treatment
    • An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers [2016]
  • European Journal of Cancer
    • Clinical practice guidelines for BRCA1 and BRCA2 genetic testing [2021]
  • Genetics in Medicine
    • The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome [2019]
  • Journal of Oncology
    • Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines [2020]
  • NPJ Genomic Medicine
    • Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices [2018]
• North Africa
  • BMC Cancer
    • Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa [2022]
• Norway
  • Norwegian Institute of Public Health
    • Genetic Tests for Breast and Ovarian Cancer [2008]
• Republic of Korea
  • Cancers
    • A Population-Based Analysis of BRCA1/2 Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study [2021]
  • Journal of Gynecologic Oncology
    • Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO) [2016]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes [2015]
• Slovenia
  • BMC Cancer
    • Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines [2021]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM clinical guidelines in Hereditary Breast and ovarian cancer [2015]
• Switzerland
  • Swiss Medical Weekly
    • Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer [2021]
• United Kingdom
  • Journal of Medical Genetics
    • Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group [2018]
  • NHS England
    • Genetic Testing for BRCA1 and BRCA2 Mutations [2015]
  • Royal College of Obstetricians and Gynaecologists
    • Management of Women with a Genetic Predisposition to Gynaecological Cancers [2015]
• United States
  • American College of Medical Genetics and Genomics
    • A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment [2014]
  • American College of Obstetricians and Gynecologists
    • Hereditary Cancer Syndromes and Risk Assessment [2019]
    • Cascade Testing: Testing Women for Known Hereditary Genetic Mutations Associated With Cancer [2018]
  • Cancer
    • BRCA testing in unaffected young women in the United States, 2006-2017 [2020]
  • Centers for Disease Control and Prevention
    • BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18–64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas — United States, 2009–2014 [2017]
    • Hereditary Breast and Ovarian Cancer
  • EBioMedicine
    • Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations [2015]
  • Hereditary Cancer in Clinical Practice
    • Evaluation and comparison of hereditary Cancer guidelines in the population [2021]
  • JAMA Network Open
    • Trends in Positive BRCA Test Results Among Older Women in the United States, 2008-2018 [2020]
  • National Cancer Institute
    • Genetics of Breast and Gynecologic Cancers (PDQ®)
  • National Comprehensive Cancer Network
    • Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology [2021]
    • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 [2017]
  • Society of Gynecologic Oncology
    • Genetics Toolkit [2020]
    • Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review [2019]
    • Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper [2017]
    • Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions [2015]
  • U.S. Preventive Services Task Force
    • BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing [2019]
• {Related topics}
  • Guidelines
    • Gynecologic oncology
    • Familial breast cancer

Ovarian cancer

• Australia
  • Australian Journal of General Practice
    • Advances in epithelial ovarian cancer [2020]
  • Cancer Australia
    • Report to the nation - ovarian cancer 2012 [2012]
    • Recommendations for the management of women at high risk of ovarian cancer [2011]
    • Management of women at high risk of ovarian cancer: a systematic review [2011]
• Canada
  • BC Cancer Agency
    • Ovary – Non-Epithelial Carcinoma
    • Ovary - Epithelial Carcinoma
  • Canadian Cancer Society
    • Ovarian cancer
  • CMAJ
    • Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants [2019]
• Denmark
  • Gynecologic Oncology
    • Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study [2022]
• Europe
  • European Society for Medical Oncology
    • ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease [2019]
    • Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2018]
    • Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2013]
  • European Society of Gynaecological Oncology
    • Non-Epithelial Ovarian Cancers in Adolescents and Young Adults [2019]
• France
  • Cancers
    • Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO [2022]
  • Journal of Clinical Medicine
    • Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer [2021]
• International
  • BMC Public Health
    • Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation [2019]
  • Carcinogenesis
    • Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research [2021]
  • Gynecologic Cancer Intergroup
    • Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference [2017]
    • Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference [2017]
  • Nature Reviews Cancer
    • Rethinking Ovarian Cancer: Recommendations for Improving Outcomes [2011]
• Republic of Korea
  • Journal of Gynecologic Oncology
    • Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement [2018]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM clinical guideline in ovarian cancer (2020) [2021]
• Switzerland
  • Swiss Medical Weekly
    • Reply to comment on: Wieser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647 [2020]
    • Comment on: Wieser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647 [2020]
    • Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data [2018]
• United Kingdom
  • Cancer Research UK
    • Ovarian cancer statistics
  • Healthcare Improvement Scotland
    • Management of epithelial ovarian cancer [2018]
  • National Institute for Health and Care Excellence
    • Quality standard for ovarian cancer [2012]
    • Ovarian cancer: The recognition and initial management of ovarian cancer [2011]
    • Ovarian cancer
  • Public Health Scotland
    • Ovarian cancer
  • Royal College of Obstetricians and Gynaecologists
    • Management of Female Malignant Ovarian Germ Cell Tumours [2016]
    • The Distal Fallopian Tube as the Origin of Non-uterine Pelvic High-grade Serous Carcinomas [2014]
    • Management of Ascites in Ovarian Cancer Patients [2014]
• United States
  • American Society of Clinical Oncology
    • Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline [2021]
  • Centers for Disease Control and Prevention
    • Ovarian Cancer
  • Journal of Women's Health
    • Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality [2016]
  • M.D. Anderson Cancer Center
    • Ovarian Cancer
  • National Cancer Institute
    • Ovarian Cancer
  • National Comprehensive Cancer Network
    • Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology [2021]
  • OncoLink
    • Ovarian Cancer
• {Related topics}
  • Guidelines
    • Ovarian cancer: treatment
    • Ovarian cancer: screening, prevention, diagnosis
    • Gynecologic oncology

Ovarian cancer: screening, prevention, diagnosis

• Australia
  • Cancer Australia
    • Technical Report on Position Statement – Testing for Ovarian Cancer in Asymptomatic Women [2019]
    • Position Statement – Testing for ovarian cancer in asymptomatic women: Technical Report [2019]
    • Position Statement on genetic testing in women diagnosed with ovarian cancer - Technical Report 2017 [2017]
    • Assessment of symptoms that may be ovarian cancer: a guide for GPs [2015]
    • Appropriate referral for women with suspected ovarian cancer [2015]
• Austria
  • Wiener klinische Wochenschrift
    • AGO Austria recommendations for genetic testing of patients with ovarian cancer [2015]
• Belgium
  • Facts, Views & Vision in ObGyn
    • The rationale of opportunistic bilateral salpingectomies (OBS) during benign gynaecological and obstetric surgery: a consensus text of the Flemish Society of Obstetrics and Gynaecology (VVOG) [2019]
• Brazil
  • Revista da Associação Médica Brasileira
    • Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT [2019]
• Brunei Darussalam
  • Asian Pacific Journal of Cancer Prevention
    • Incidence, Mortality and Survival Analysis of Epithelial Ovarian Cancer in Brunei Darussalam [2022]
• Canada
  • Journal of Medical Genetics
    • Practice guidelines for BRCA1/2 tumour testing in ovarian cancer [2022]
• China
  • Journal of Cancer Research and Therapeutics
    • A meta-analysis of serum cancer antigen 125 array for diagnosis of ovarian cancer in Chinese [2014]
• Denmark
  • International Journal of Cancer
    • Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study [2022]
• Europe
  • Annals of Oncology
    • European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer [2022]
  • British Journal of Cancer
    • An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study [2015]
  • European Menopause and Andropause Society
    • Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement [2017]
  • International Journal of Gynecological Cancer
    • Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer [2016]
  • Seminars in Oncology
    • Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients [2017]
• Gulf Cooperation Council
  • BMC Cancer
    • Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study [2021]
• Hong Kong
  • Centre for Health Protection
    • Recommendations on Prevention and Screening for Ovarian Cancer For Health Professionals [2018]
• International
  • BMC Cancer
    • Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines [2019]
    • Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis [2019]
  • Cancer Epidemiology Biomarkers & Prevention
    • Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer [2013]
  • Cancers
    • Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study [2022]
  • Carcinogenesis
    • Urinary biomarkers for the detection of ovarian cancer: a systematic review [2022]
  • Chinese Clinical Oncology
    • Epidemiology of ovarian cancer [2020]
  • Frontiers in Public Health
    • Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017 [2021]
  • International Journal of Cancer
    • The influence of birth cohort and calendar period on global trends in ovarian cancer incidence [2020]
  • International Journal of Women's Health
    • Ovarian cancer in the world: epidemiology and risk factors [2019]
  • Journal of Preventive Medicine and Hygiene
    • Worldwide incidence and mortality of ovarian cancer and Human Development Index (HDI): GLOBOCAN sources and methods 2018 [2021]
  • Lancet Oncology
    • Ovarian cancer and smoking: individual participant meta-analysis including 28114 women with ovarian cancer from 51 epidemiological studies [2012]
  • Virchows Archiv
    • Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria [2016]
• Ireland
  • Department of Health
    • Diagnosis and Staging of Patients with Ovarian Cancer [2019]
• Italy
  • Critical Reviews in Oncology/Hematology
    • Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives [2019]
• Japan
  • Nagoya Journal of Medical Science
    • Epidemiological overview of metastatic ovarian carcinoma: long-term experience of TOTSG database [2019]
• Puerto Rico
  • BioMed Research International
    • Ovarian Cancer Screening Practices of Obstetricians and Gynecologists in Puerto Rico [2014]
• Republic of Korea
  • Cancer Science
    • Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer [2021]
  • Journal of Gynecologic Oncology
    • Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012 [2015]
  • Scientific Reports
    • Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea [2021]
• Singapore
  • Asian Pacific Journal of Cancer Prevention
    • Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968-2012 [2019]
• Spain
  • Sociedad Española de Oncología Médica
    • Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology [2018]
• Taiwan
  • BMC Women's Health
    • Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan [2021]
  • International Journal of Environmental Research and Public Health
    • Different Influences of Endometriosis and Pelvic Inflammatory Disease on the Occurrence of Ovarian Cancer [2021]
• United Kingdom
  • BMC Medicine
    • Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation [2016]
  • National Institute for Health and Care Excellence
    • Tests in secondary care to identify people at high risk of ovarian cancer [2017]
  • Royal College of Obstetricians and Gynaecologists
    • The Use of Biomarkers to Stratify Surgical Care in Women with Ovarian Cancer [2022]
    • Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause [2021]
• United States
  • Agency for Healthcare Research and Quality
    • Screening for Ovarian Cancer [2018]
  • American College of Obstetricians and Gynecologists
    • Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention [2019]
    • The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk [2017]
  • American College of Radiology
    • Staging and Follow-Up of Ovarian Cancer
    • Ovarian Cancer Screening
  • American Society of Clinical Oncology
    • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline [2020]
    • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
  • BMJ Quality & Safety
    • When evidence says no: gynaecologists’ reasons for (not) recommending ineffective ovarian cancer screening [2020]
  • Cancer Epidemiology Biomarkers & Prevention
    • Population Distribution of Lifetime Risk of Ovarian Cancer in the United States [2015]
  • National Cancer Institute
    • Frequency of mismatch repair deficiency in ovarian cancer: A systematic review [2011]
  • Society of Gynecologic Oncology
    • Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer [2015]
    • SGO Clinical Practice Statement: Genetic Testing for Ovarian Cancer [2014]
    • SGO Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention [2013]
  • U.S. Preventive Services Task Force
    • Ovarian Cancer: Screening [2018]
• WHO
  • International Agency for Research on Cancer
    • Ovary fact sheet
  • World Health Organization
    • Ovary cancer
• {Related topics}
  • Guidelines
    • Ovarian cancer

Ovarian cancer: treatment

• Australia
  • Cancer Australia
    • Ovarian cancer chemotherapy recommendations: approaches to support uptake- Forum report 2013 [2013]
    • Follow up of women with epithelial ovarian cancer [2012]
• Belgium
  • PLoS ONE
    • First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis [2018]
• Canada
  • Current Oncology
    • Systemic therapy for recurrent epithelial ovarian cancer: a clinical practice guideline [2017]
  • Gynecologic Oncology
    • Spatial Analysis of Adherence to Treatment Guidelines for Advanced-Stage Ovarian Cancer and the Impact of Race and Socioeconomic Status [2014]
  • Ontario Health
    • Systemic Therapy for Recurrent Epithelial Ovarian Cancer [2017]
    • Adjuvant Care for Stage I Ovarian Cancer [2016]
• Europe
  • European Society for Medical Oncology
    • ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer [2020]
  • European Society of Gynaecological Oncology
    • Ovarian cancer surgery [2017]
    • ESGO Advanced (stage III-IV) Ovarian Cancer Surgery Quality Indicators [2016]
• France
  • Annals of Surgical Oncology
    • Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group [2021]
• Germany
  • Institute for Quality and Efficiency in Health Care
    • Rucaparib (ovarian cancer; maintenance treatment) - Benefit assessment according to §35a Social Code Book V [2019]
• International
  • Clinical Cancer Research
    • Small Cell Carcinoma of the Ovary, Hypercalcaemic Type – genetics, new treatment targets and current management guidelines [2020]
  • European Society of Gynaecological Oncology
    • ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors [2021]
  • Gynecologic Cancer Intergroup
    • Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer [2020]
    • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease [2017]
    • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions [2017]
    • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours [2017]
  • International Journal of Gynecological Cancer
    • Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care [2020]
  • World Journal of Surgical Oncology
    • Outcome quality standards in advanced ovarian cancer surgery [2020]
• Italy
  • Journal of Ovarian Research
    • Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status [2019]
• Netherlands
  • Gynecologic Oncology Reports
    • Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus [2022]
• Republic of Korea
  • ClinicoEconomics and Outcomes Research
    • Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model [2013]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Front-Line Systemic Therapy of Newly Diagnosed Advanced Epithelial Ovarian Cancer [2015]
• Spain
  • Clinical and Translational Oncology
    • GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012 [2013]
  • Journal of Ovarian Research
    • Management of advanced ovarian cancer in Spain: an expert Delphi consensus [2021]
  • Virchows Archiv
    • Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH) [2020]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of epithelial ovarian cancers [2021]
• United Kingdom
  • Healthcare Improvement Scotland
    • Ovarian Cancer Clinical Quality Performance Indicators [2016]
  • National Institute for Health and Care Excellence
    • Maximal cytoreductive surgery for advanced ovarian cancer [2023]
    • Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal) [2019]
    • Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer [2016]
    • Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment [2013]
    • Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer [2013]
    • Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer [2013]
  • Royal College of Obstetricians and Gynaecologists
    • Targeted therapies for the management of ovarian cancer [2013]
• United States
  • American Society of Clinical Oncology
    • PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline [2020]
    • PARP Inhibitors in the Management of Ovarian Cancer
    • Neoadjuvant Chemotherapy for Ovarian Cancer
  • Annals of Surgical Oncology
    • Is it time to centralize ovarian cancer care in the United States? [2016]
  • Cancer
    • The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms [2020]
  • Food and Drug Administration
    • FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy [2015]
  • Gynecologic Oncology
    • Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival [2014]
  • International Journal of Gynecological Cancer
    • National trends in bowel and upper abdominal procedures in ovarian cancer surgery [2020]
  • JAMA Network Open
    • Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016 [2020]
  • Journal of the National Cancer Institute
    • Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status [2013]
  • National Cancer Institute
    • Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup (GCIG) and United States National Cancer Institute (NCI) clinical trials planning meeting, May, 2009 [2010]
    • Ovarian Low Malignant Potential Tumors Treatment (PDQ®)
    • Ovarian Germ Cell Tumors Treatment (PDQ®)
    • Childhood Ovarian Cancer Treatment (PDQ®)
  • Obstetrics & Gynecology
    • Trends in Relative Survival for Ovarian Cancer From 1975 to 2011 [2015]
    • Racial Disparities in the Treatment of Advanced Epithelial Ovarian Cancer [2013]
  • PLoS ONE
    • Trends in extent of surgical cytoreduction for patients with ovarian cancer [2021]
  • Society of Gynecologic Oncology
    • FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper [2017]
    • Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline [2016]
    • SGO guidance document for clinical trial designs in ovarian cancer: A changing paradigm [2014]
    • Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper [2014]
• {Related topics}
  • Guidelines
    • Ovarian cancer

Tubal cancer

• Canada
  • BC Cancer Agency
    • Fallopian Tube
  • Canadian Cancer Society
    • Fallopian tube cancer
• Taiwan
  • Taiwanese Journal of Obstetrics and Gynecology
    • Primary fallopian tube cancer: Domestic data and up-to-date review [2014]
• United States
  • Journal of the National Cancer Institute
    • Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries [2018]
  • M.D. Anderson Cancer Center
    • Fallopian Tube Cancer
  • OncoLink
    • Fallopian Tube Cancer
• {Related topics}
  • Guidelines
    • Gynecologic oncology

Uterine sarcoma

• Austria, Germany
  • Geburtshilfe und Frauenheilkunde
    • Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019) [2019]
• Canada
  • BC Cancer Agency
    • Gynecological Sarcoma
  • Current Oncology
    • Chemotherapy (gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) in inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a clinical practice guideline [2013]
  • Ontario Health
    • Guidance for the Management of Gynecologic Sarcomas in Ontario: Recommendations Report 2017 [2017]
• International
  • International Collaboration on Cancer Reporting
    • Uterine Malignant and Potentially Malignant Mesenchymal Tumours [2021]
  • International Federation of Gynecology and Obstetrics
    • Uterine sarcomas [2018]
  • International Journal of Gynecological Cancer
    • Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma [2014]
• Mexico
  • International Journal of Surgery
    • Uterine sarcomas: Review of 26 years at The Instituto Nacional de Cancerologia of Mexico [2013]
• Taiwan
  • Taiwanese Journal of Obstetrics and Gynecology
    • Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review [2016]
    • Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review [2016]
    • Uterine sarcoma Part III—Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review [2016]
• United Kingdom
  • Clinical Sarcoma Research
    • UK guidelines for the management of soft tissue sarcomas [2016]
  • Royal College of Pathologists
    • Dataset for histopathological reporting of uterine sarcomas [2018]
• United States
  • American Cancer Society
    • Uterine Sarcoma
  • Journal of Gynecologic Oncology
    • Trends of uterine carcinosarcoma in the United States [2018]
  • National Cancer Institute
    • Uterine Sarcoma Treatment (PDQ®)
• {Related topics}
  • Guidelines
    • Gynecologic oncology

Vaginal cancer

• Canada
  • BC Cancer Agency
    • Vagina
  • Canadian Cancer Society
    • Vaginal cancer
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018) [2019]
• International
  • International Collaboration on Cancer Reporting
    • Carcinomas of the Vagina [2021]
  • International Federation of Gynecology and Obstetrics
    • Cancer of the vagina: 2021 update [2021]
    • Cancer of the vagina [2018]
• United Kingdom
  • Cancer Research UK
    • Vaginal cancer statistics
• United States
  • American College of Radiology
    • Management of vaginal cancer
  • eMedicine
    • Vaginal Cancer Treatment Protocols [2017]
  • M.D. Anderson Cancer Center
    • Vaginal Cancer
  • National Cancer Institute
    • Vaginal Cancer Treatment (PDQ®)
  • OncoLink
    • Vaginal Cancer
• WHO
  • International Agency for Research on Cancer
    • Vagina fact sheet
• {Related topics}
  • Guidelines
    • Gynecologic oncology

Vulvar cancer

• Australasia
  • Royal College of Pathologists of Australasia
    • Vulva
• Australia
  • Cancer Australia
    • The role of sentinel lymph node biopsy in the treatment of women with early stage vulval cancer: A systematic review [2015]
    • The role of sentinel lymph node biopsy in the treatment of women with early stage vulval cancer: A summary of the evidence [2015]
• Canada
  • BC Cancer Agency
    • Vulva
  • Canadian Cancer Society
    • Vulvar cancer
  • Ontario Health
    • Sentinel Lymph Node Biopsy in Vulvar Cancer [2018]
  • Society of Obstetricians and Gynaecologists of Canada
    • Management of Squamous Cell Cancer of the Vulva [2019]
• Europe
  • European Society of Gynaecological Oncology
    • The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions [2022]
    • Vulvar cancer [2016]
  • European Society of Urogenital Radiology
    • Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR) [2021]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015 [2016]
  • PLoS ONE
    • Incidence Patterns and Temporal Trends of Invasive Nonmelanotic Vulvar Tumors in Germany 1999-2011. A Population-Based Cancer Registry Analysis [2015]
• International
  • Cancers
    • New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors [2022]
    • How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature [2021]
  • International Collaboration on Cancer Reporting
    • Carcinomas of the Vulva [2021]
  • International Federation of Gynecology and Obstetrics
    • Cancer of the vulva: 2021 update [2021]
    • Cancer of the vulva [2018]
  • International Journal of Gynecological Pathology
    • Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer [2020]
  • International Society of the Study of Vulvovaginal Diseases
    • Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation [2021]
  • PLoS ONE
    • Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis [2018]
  • Ultrasound in Obstetrics & Gynecology
    • Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group [2021]
• Italy
  • Journal of Cancer Research and Clinical Oncology
    • Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT [2020]
• Netherlands
  • International Journal of Cancer
    • Vulvar intraepithelial neoplasia: Incidence and long-term risk of vulvar squamous cell carcinoma [2021]
• Poland
  • Ginekologia Polska
    • Analysis of incidence and overall survival of patients with vulvar cancer in Poland in 2008–2016 — implications for cancer registries [2022]
• Republic of Korea
  • Journal of Korean Medical Science
    • Prevalence and Treatment of Vulvar Cancer From 2014-2018: A Nationwide Population-Based Study in Korea [2022]
• Sri Lanka
  • Sri Lanka College of Obstetricians & Gynaecologists
    • Management of vulval cancer [2021]
• United Kingdom
  • Cancer Research UK
    • Vulval cancer statistics
  • Royal College of Pathologists
    • Dataset for histopathological reporting of vulval carcinomas [2018]
• United States
  • American College of Obstetricians and Gynecologists
    • Management of Vulvar Intraepithelial Neoplasia [2016]
  • American College of Radiology
    • ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer [2015]
    • Adjuvant Therapy in Vulvar Cancer
  • M.D. Anderson Cancer Center
    • Vulvar Cancer
  • National Cancer Institute
    • Vulvar Cancer Treatment (PDQ®)
    • Vulvar Cancer
  • National Comprehensive Cancer Network
    • Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology [2017]
    • Vulvar Cancer
  • OncoLink
    • Vulvar Cancer
• WHO
  • International Agency for Research on Cancer
    • Vulva fact sheet
• {Related topics}
  • Guidelines
    • Vulvar diseases
    • Gynecologic oncology